1 | 0.03% using A foot pump | - | - | - | - | 1件: 97 97 💬
|
2 | 0.25 MG RPC103 | - | - | - | - | 1件: 97 97 💬
|
3 | 0.25 MG RPC1063 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
4 | 0.25MG RPC103 | - | - | - | - | 1件: 97 97 💬
|
5 | 0.25MG RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
6 | 0.5 MG RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
7 | 1 MG RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
8 | 1 serving OF broccoli sprouts | - | - | - | - | 1件: 97 97 💬
|
9 | 1.0 MG RPC103 | - | - | - | - | 1件: 97 97 💬
|
10 | 1.0 MG RPC1063 | - | - | - | - | 1件: 97 97 💬
|
11 | 1.remicade | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
12 | 10 MG natura-alpha capsule | - | - | - | - | 1件: 97 97 💬
|
13 | 100 MG | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
14 | 100% pomegranate juice | - | - | - | - | 2件: 96 96, 97 💬
|
15 | 1500MG mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
16 | 15n2-tofacitinib | - | - | - | - | 1件: 97 97 💬
|
17 | 2 X 10 MG natura-alpha capsules | - | - | - | - | 1件: 97 97 💬
|
18 | 2'-fucosyllactose | - | - | - | - | 2件: 96 96, 97 💬
|
19 | 20 MG | - | - | - | - | 1件: 97 97 💬
|
20 | 23-valent polysaccharide pneumococcal vaccine | - | - | - | - | 2件: 96 96, 97 💬
|
21 | 25 MG ontamalimab | - | - | - | - | 2件: 96 96, 97 💬
|
22 | 250MG mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
23 | 2L polyethylene glycol/ascorbic acid | - | - | - | - | 1件: 97 97 💬
|
24 | 2ML peripheral venous blood WAS collected TO detect genetic genes | - | - | - | - | 1件: 97 97 💬
|
25 | 3 bottles OF lactulose oral solution | - | - | - | - | 1件: 97 97 💬
|
26 | 3 servings OF broccoli sprouts | - | - | - | - | 1件: 97 97 💬
|
27 | 331731-18-1 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
28 | 3L-polyethylene glycol | - | - | - | - | 1件: 97 97 💬
|
29 | 40 MG MSB11022 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
30 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | 1件: 97 97 💬
|
31 | 5-amino salicylic acid | - | - | - | - | 1件: 97 97 💬
|
32 | 5-amino-2-hydroxybenzoic acid | - | - | - | - | 1件: 97 97 💬
|
33 | 5-aminosalicyclic acid | - | - | - | - | 1件: 97 97 💬
|
34 | 5-aminosalicylic acid | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
35 | 5-aminosalicylic acid(5-ASA) and/or prednisone | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
36 | 5-ASA | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
37 | 5-ASA MMX | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
38 | 5-HTP | - | - | - | - | 2件: 96 96, 97 💬
|
39 | 50 MG | - | - | - | - | 1件: 97 97 💬
|
40 | 500MG mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
41 | 549-0261/F02-01 | - | - | - | - | 2件: 96 96, 97 💬
|
42 | 6 mercaptopurine | - | - | - | - | 2件: 96 96, 97 💬
|
43 | 6-[2-(3,4-diethoxyphenyl)thiazol-4-YL] pyridine-2-carboxylic acid | - | - | - | - | 1件: 97 97 💬
|
44 | 6-mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: hprT hprT 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 3件: 96 96, 97, 164 💬
|
45 | 6-MP | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: hprT hprT 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
46 | 68GA-fapi | - | - | - | - | 3件: 46 46, 97, 300 💬
|
47 | 75 MG ontamalimab | - | - | - | - | 2件: 96 96, 97 💬
|
48 | 750MG mesalazine pellets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
49 | 90 MG hydrocortisone acetate suppository with sephure suppository applicator | 3件: Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | 2件: Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
50 | 90 MG idrocortisone acetato IN supposta CON applicatore PER supposte sephure | - | - | - | - | 1件: 97 97 💬
|
51 | A plant based high fiber diet that mimics fasting (FMD) plus advanced therapy | - | - | - | - | 1件: 97 97 💬
|
52 | A07da03 | - | - | - | - | 1件: 97 97 💬
|
53 | A: 1 dosis | - | - | - | - | 1件: 97 97 💬
|
54 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 2 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
55 | ABBV-006 | - | - | - | - | 1件: 97 97 💬
|
56 | ABBV-066 | - | - | - | - | 2件: 96 96, 97 💬
|
57 | ABBV-323 | - | - | - | - | 2件: 53 53, 97 💬
|
58 | ABBV-323 dose A | - | - | - | - | 1件: 97 97 💬
|
59 | ABBV-323 dose B | - | - | - | - | 1件: 97 97 💬
|
60 | ABBV-668 | - | - | - | - | 1件: 97 97 💬
|
61 | Abbvie care 2.0 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
62 | ABI-M201 | - | - | - | - | 1件: 97 97 💬
|
63 | Abrilumab | 1件: Abrilumab Abrilumab | 1件: Abrilumab
Abrilumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
64 | ABT-494 | - | - | - | - | 7件: 41 41, 46, 49, 96, 97, 107, 271 💬
|
65 | ABT-humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
66 | ABX464 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
67 | ABX464 100MG | - | - | - | - | 2件: 46 46, 97 💬
|
68 | ABX464 25MG | - | - | - | - | 1件: 97 97 💬
|
69 | ABX464 50MG | - | - | - | - | 2件: 46 46, 97 💬
|
70 | Acacia GUM | 1件: Acacia Acacia | 1件: Acacia
Acacia
💬
| - | - | 1件: 97 97 💬
|
71 | Accelerated 1 HOUR-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
72 | Accelerated 30 minutes-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
73 | Accelerated HBV vaccine | - | - | - | - | 1件: 97 97 💬
|
74 | Acceptance and commitment therapy | - | - | - | - | 1件: 97 97 💬
|
75 | Acetate | 1件: Acetate Acetate | - | - | - | 14件: 11 11, 46, 49, 51, 70, 71, 73, 76, 89, 97, 158, 235, 265, 299 💬
|
76 | Acetato DI ammonio | - | - | - | - | 1件: 97 97 💬
|
77 | Acetic acid | 1件: Acetic acid Acetic acid | 1件: Acetic acid, glacial
Acetic acid, glacial
💬
| - | - | 2件: 97 97, 296 💬
|
78 | Acetylcarnitine | 1件: Acetylcarnitine Acetylcarnitine | - | - | - | 3件: 2 2, 97, 265 💬
|
79 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 10件: 34 34, 51, 53, 85, 94, 97, 193, 233, 298, 299 💬
|
80 | Acidophilus | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 1件: 97 97 💬
|
81 | Aclasta | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 3件: 97 97, 271, 274 💬
|
82 | Actavis ferrous sulphate tablets BP 200MG | - | - | - | - | 1件: 97 97 💬
|
83 | Actonel once A week 35MG | - | - | - | - | 1件: 97 97 💬
|
84 | Adalimumab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 18件: 19 19, 37, 40, 41, 46, 55, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
|
85 | Adalimumab 40MG | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
86 | Adalimumab-680LT | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
87 | Adalimumab-800CW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
88 | Additional therapies | - | - | - | - | 1件: 97 97 💬
|
89 | Adipose derived, autologous mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
90 | Adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
91 | Adrenomedullin | 1件: Adrenomedullin Adrenomedullin | - | - | - | 3件: 96 96, 97, 124 💬
|
92 | Advanced therapy | - | - | - | - | 1件: 97 97 💬
|
93 | Advanced therapy only without dietary intervention | - | - | - | - | 1件: 97 97 💬
|
94 | AEB071 | - | - | - | - | 1件: 97 97 💬
|
95 | AEB071A | - | - | - | - | 1件: 97 97 💬
|
96 | AERO-RED 100 MG/ML gotas orales EN solucióN | - | - | - | - | 2件: 96 96, 97 💬
|
97 | AG011 | - | - | - | - | 1件: 97 97 💬
|
98 | AG011 - capsules | - | - | - | - | 1件: 97 97 💬
|
99 | AG011 - enema | - | - | - | - | 1件: 97 97 💬
|
100 | AIN457 | - | - | - | - | 9件: 13 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
|
101 | AIR | - | - | - | - | 2件: 85 85, 97 💬
|
102 | AIR insufflation insertion | - | - | - | - | 1件: 97 97 💬
|
103 | AIRE-2 portable breath analyzer | - | - | - | - | 1件: 97 97 💬
|
104 | AJM300 | - | - | - | - | 1件: 97 97 💬
|
105 | AK101 IV/AK101 SC | - | - | - | - | 1件: 97 97 💬
|
106 | Aldesleukin | 1件: Aldesleukin Aldesleukin | 1件: Aldesleukin
Aldesleukin
💬
| 3件: IL2RA IL2RA, IL2RB, IL2RG 💬
| 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 5件: 2 2, 49, 65, 96, 97 💬
|
107 | Alequel | - | - | - | - | 2件: 96 96, 97 💬
|
108 | Algin | 1件: Alginic acid Alginic acid | 2件: Alginic acid
Alginic acid
,
Sodium alginate
💬
| - | - | 1件: 97 97 💬
|
109 | Alicaforsen | 1件: Alicaforsen Alicaforsen | 1件: Alicaforsen sodium
Alicaforsen sodium
💬
| 1件: ICAM1 ICAM1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Cell adhesion molecules, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Human T-cell leukemia virus 1 infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Staphylococcus aureus infection, TNF signaling pathway, Viral myocarditis 💬 | 2件: 96 96, 97 💬
|
110 | Alkaline phosphatase | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 3件: 46 46, 93, 97 💬
|
111 | Allogeneic adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
112 | Allogeneic bone marrow-derived mesenchymal stromal cells | 1件: Allogenic bone marrow-derived mesenchymal stem cells Allogenic bone marrow-derived mesenchymal stem cells | - | - | - | 1件: 97 97 💬
|
113 | Allopurinol | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬
|
114 | Allopurinol sodium | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
115 | Allorx | - | - | - | - | 8件: 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
116 | Aloasc | - | - | - | - | 1件: 97 97 💬
|
117 | Aloe barbadensis miller | 1件: Aloe vera leaf Aloe vera leaf | 1件: Aloe
Aloe
💬
| - | - | 1件: 97 97 💬
|
118 | Aloe vera GEL | 1件: Aloe vera leaf Aloe vera leaf | 1件: Aloe
Aloe
💬
| - | - | 1件: 97 97 💬
|
119 | Also referred TO AS 'MEDI2070' | - | - | - | - | 1件: 97 97 💬
|
120 | Also referred TO AS MEDI2070 | - | - | - | - | 2件: 96 96, 97 💬
|
121 | ALTB-168 | - | - | - | - | 1件: 97 97 💬
|
122 | ALTB-268 | - | - | - | - | 1件: 97 97 💬
|
123 | ALTH12-1:4 | - | - | - | - | 1件: 97 97 💬
|
124 | ALTH12-2:4 | - | - | - | - | 1件: 97 97 💬
|
125 | AMG 181 | - | - | - | - | 2件: 96 96, 97 💬
|
126 | AMG 592 | - | - | - | - | 3件: 46 46, 49, 97 💬
|
127 | AMG181 | - | - | - | - | 1件: 97 97 💬
|
128 | Amgevita | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
129 | Amgevita 40 MG injektionslösung IM fertigpen | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
130 | Amgevita 40 MG injektionslösung IN einer fertigspritze | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
131 | Amgevita 40MG solution FOR injection | - | - | - | - | 2件: 96 96, 97 💬
|
132 | Amino acid mixture beverage | - | - | - | - | 1件: 97 97 💬
|
133 | Amino salicylic acid | - | - | - | - | 1件: 97 97 💬
|
134 | Aminosalicylic acid | 1件: Aminosalicylic acid Aminosalicylic acid | 1件: Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | 2件: 96 96, 97 💬
|
135 | Amiselimod | 1件: Amiselimod Amiselimod | 1件: Amiselimod
Amiselimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 97 97 💬
|
136 | Amitriptyline hydrochloride | 1件: Amitriptyline Amitriptyline | 2件: Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 97 97 💬
|
137 | Amoxicillin | 2件: Amoxicillin Amoxicillin, Clavulanic acid | 5件: Amoxicillin
Amoxicillin
,
Clavulanate potassium
,
Amoxicillin sodium
,
Amoxicillin
,
Clavulanic acid
💬
| - | - | 5件: 46 46, 63, 96, 97, 299 💬
|
138 | Amoxicillin and doxycyclin | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 97 97 💬
|
139 | Amoxicillin, metronidazole and doxycycline | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 97 97 💬
|
140 | AMT-101 | 1件: AMT-101 AMT-101 | - | - | - | 2件: 46 46, 97 💬
|
141 | Anakinra | 1件: Anakinra Anakinra | 1件: Anakinra
Anakinra
💬
| 2件: IL1R1 IL1R1, IL1R2 💬
| 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 19件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬
|
142 | Andecaliximab | 1件: Andecaliximab Andecaliximab | 1件: Andecaliximab
Andecaliximab
💬
| 1件: MMP9 MMP9 💬
| 15件: Bladder cancer Bladder cancer, Diabetic cardiomyopathy, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Hepatitis B, IL-17 signaling pathway, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Relaxin signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | 5件: 46 46, 96, 97, 272, 299 💬
|
143 | Andosan | - | - | - | - | 2件: 96 96, 97 💬
|
144 | Andrographis paniculata | - | - | - | - | 1件: 97 97 💬
|
145 | Andrographolide | 1件: Andrographolide Andrographolide | - | - | - | 1件: 97 97 💬
|
146 | Anhidrous sodium sulfate | 1件: Sodium sulfate Sodium sulfate | 2件: Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | 1件: 97 97 💬
|
147 | Anhydrous sodium sulfate | 1件: Sodium sulfate Sodium sulfate | 2件: Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | 1件: 97 97 💬
|
148 | Anrukinzumab | 1件: Anrukinzumab Anrukinzumab | 1件: Anrukinzumab
Anrukinzumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 97 97 💬
|
149 | Anti BETA7 | - | - | - | - | 1件: 97 97 💬
|
150 | Anti CD3 monoclonal antibody | - | - | - | - | 1件: 97 97 💬
|
151 | Anti TNF therapy including infliximab | - | - | - | - | 2件: 96 96, 97 💬
|
152 | ANTI-CD3 monoclonal antibody | 1件: Muromonab Muromonab | 1件: Muromonab-CD3
Muromonab-CD3
💬
| 3件: CD3D CD3D, CD3E, CD3G 💬
| 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬
|
153 | ANTI-interleukin-23 immunoglobulin G2 (IGG2) human monoclonal antibody | - | - | - | - | 2件: 96 96, 97 💬
|
154 | ANTI-IP-10 antibody | - | - | - | - | 1件: 97 97 💬
|
155 | ANTI-madcam antibody | - | - | - | - | 2件: 96 96, 97 💬
|
156 | ANTI-TL1A | - | - | - | - | 1件: 97 97 💬
|
157 | ANTI-TNF | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
158 | ANTI-TNF discontinuation: physiological saline solution | - | - | - | - | 2件: 96 96, 97 💬
|
159 | ANTI-TNF drug | - | - | - | - | 2件: 96 96, 97 💬
|
160 | ANTI-TNF therapy | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
161 | ANTI-tumor necrosis factor alpha agents | - | - | - | - | 1件: 97 97 💬
|
162 | Antibiotic cocktail | - | - | - | - | 1件: 97 97 💬
|
163 | Antibiotics | - | - | - | - | 2件: 96 96, 97 💬
|
164 | Antibodies TO golimumab | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
165 | Antigeno superficie hepatitis B | - | - | - | - | 1件: 97 97 💬
|
166 | Antioxidant diet | - | - | - | - | 1件: 97 97 💬
|
167 | Anxiety/depression questionnaires | - | - | - | - | 1件: 97 97 💬
|
168 | APD334 | - | - | - | - | 5件: 93 93, 96, 97, 98, 269 💬
|
169 | APD334 L-arginine | - | - | - | - | 1件: 97 97 💬
|
170 | Apigenin | 1件: Apigenin Apigenin | - | - | - | 1件: 97 97 💬
|
171 | Apixaban 2.5 milligram | 1件: Apixaban Apixaban | 1件: Apixaban
Apixaban
💬
| 1件: F10 F10 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 96 96, 97 💬
|
172 | APL-1401 | - | - | - | - | 1件: 97 97 💬
|
173 | Appendectomy | - | - | - | - | 1件: 97 97 💬
|
174 | Apremilast | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 7件: 46 46, 50, 56, 97, 107, 162, 271 💬
|
175 | Apriso 0.375G ER CAP | - | - | - | - | 1件: 97 97 💬
|
176 | Apriso 375 MG extended-release capsules | - | - | - | - | 1件: 97 97 💬
|
177 | APVO210 | - | - | - | - | 1件: 97 97 💬
|
178 | Aquamin | - | - | - | - | 1件: 97 97 💬
|
179 | AR401959 L-arginine | - | - | - | - | 3件: 96 96, 97, 98 💬
|
180 | ARM 2 | - | - | - | - | 1件: 97 97 💬
|
181 | ARM B- standard OF care | - | - | - | - | 1件: 97 97 💬
|
182 | ARM1 | - | - | - | - | 1件: 97 97 💬
|
183 | Asacol | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
184 | Asacol (mesalamine) delayed-release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
185 | Asacol 400 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
186 | Asacol 400 MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
187 | Asacol 400MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
188 | Asacol 800 MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
189 | Asacol 800MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
190 | Asacol delayed release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
191 | Asacol delayed-release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
192 | Asacol® 400 MG | - | - | - | - | 1件: 97 97 💬
|
193 | ASC | - | - | - | - | 1件: 97 97 💬
|
194 | Ascorbic acid | 1件: Ascorbic acid Ascorbic acid | 1件: Ascorbic acid
Ascorbic acid
💬
| - | - | 4件: 10 10, 97, 206, 298 💬
|
195 | Ascs | - | - | - | - | 2件: 53 53, 97 💬
|
196 | Ascs:adipose derived stem cells | - | - | - | - | 1件: 97 97 💬
|
197 | ASP015K | - | - | - | - | 2件: 46 46, 97 💬
|
198 | ASP3291 | - | - | - | - | 1件: 97 97 💬
|
199 | Aspergillus oryzae | 1件: Aspergillus oryzae Aspergillus oryzae | - | - | - | 1件: 97 97 💬
|
200 | Aspirin 81MG EC TAB | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 96 96, 97 💬
|
201 | Assessment OF biological factors | - | - | - | - | 1件: 97 97 💬
|
202 | Assessment OF genetics | - | - | - | - | 1件: 97 97 💬
|
203 | Assessment OF psychophysiological factors | - | - | - | - | 1件: 97 97 💬
|
204 | Assessment OF quality OF life | - | - | - | - | 2件: 6 6, 97 💬
|
205 | AST-120 | - | - | - | - | 2件: 96 96, 97 💬
|
206 | ATH-063 | - | - | - | - | 2件: 96 96, 97 💬
|
207 | ATL-2502 | 1件: ATL-2502 ATL-2502 | - | - | - | 1件: 97 97 💬
|
208 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 17件: 13 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
|
209 | Atorvastatin 80MG | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 97 97 💬
|
210 | Atorvastatin calcium | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 2件: 97 97, 265 💬
|
211 | Autologous platelet-poor plasma (PPP) and thrombin coagulum treatment | - | - | - | - | 1件: 97 97 💬
|
212 | Autologous platelet-rich plasma (PRP) and thrombin coagulum treatment | - | - | - | - | 1件: 97 97 💬
|
213 | Avonex | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 13 13, 97 💬
|
214 | AVT16 | - | - | - | - | 1件: 97 97 💬
|
215 | AVX 470 | - | - | - | - | 1件: 97 97 💬
|
216 | AZA | - | - | - | - | 4件: 11 11, 40, 96, 97 💬
|
217 | Azafor - 50 MG compresse rivestite CON film 50 compresse IN blister PVC/pvdc/AL | - | - | - | - | 1件: 97 97 💬
|
218 | Azafor 50MG | - | - | - | - | 1件: 97 97 💬
|
219 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
220 | Azathioprine (imuran) 50 MG overencapsulated tablet | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
221 | Azathioprine / allopurinol | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
222 | Azathioprine and allopurinol | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
223 | Azathioprine BP | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
224 | Azatioprina | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 2件: 96 96, 97 💬
|
225 | B03A A07 | - | - | - | - | 1件: 97 97 💬
|
226 | B03ac06 | - | - | - | - | 1件: 97 97 💬
|
227 | B2-asmedic | - | - | - | - | 1件: 97 97 💬
|
228 | B: 2 dosis | - | - | - | - | 1件: 97 97 💬
|
229 | Bacteriotherapy | - | - | - | - | 2件: 96 96, 97 💬
|
230 | Baitouweng tang | - | - | - | - | 1件: 97 97 💬
|
231 | Balsalazide | 1件: Balsalazide Balsalazide | 2件: Balsalazide disodium
Balsalazide disodium
,
Balsalazide
💬
| - | - | 1件: 97 97 💬
|
232 | Balsalazide disodium | 1件: Balsalazide Balsalazide | 2件: Balsalazide disodium
Balsalazide disodium
,
Balsalazide
💬
| - | - | 1件: 97 97 💬
|
233 | Baminercept | 1件: Baminercept Baminercept | 1件: Baminercept
Baminercept
💬
| 1件: LTB LTB 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 53, 97 💬
|
234 | Bascial prescription plus or minus herbs depend ON symptoms | - | - | - | - | 1件: 97 97 💬
|
235 | Basiliximab | 1件: Basiliximab Basiliximab | 1件: Basiliximab
Basiliximab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 5件: 2 2, 50, 97, 222, 228 💬
|
236 | BBT-401-1S | - | - | - | - | 1件: 97 97 💬
|
237 | BBT-401-1S, multiple doses | - | - | - | - | 1件: 97 97 💬
|
238 | BBT-401-1S, single dose | - | - | - | - | 1件: 97 97 💬
|
239 | Beclometasone | - | - | - | - | 1件: 97 97 💬
|
240 | Beclometasone dipropionate | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 3件: Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 85 85, 97 💬
|
241 | Beclomethasone dipropionate IN addition TO MC-evoo | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 3件: Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
242 | Beclomethasone dipropionate IN addition TO refined OIL | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 3件: Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
243 | Beclomethasone diproprionate | - | - | - | - | 1件: 97 97 💬
|
244 | Behavioral counseling | - | - | - | - | 1件: 97 97 💬
|
245 | Berberine | 1件: Berberine Berberine | 1件: Coptis rhizome
Coptis rhizome
💬
| - | - | 3件: 46 46, 97, 265 💬
|
246 | Berberine chloride | 1件: Berberine Berberine | 1件: Coptis rhizome
Coptis rhizome
💬
| - | - | 1件: 97 97 💬
|
247 | Bertilimumab | 1件: Bertilimumab Bertilimumab | - | - | - | 2件: 97 97, 162 💬
|
248 | Best medical therapy | - | - | - | - | 1件: 97 97 💬
|
249 | BETA-1,3/1,6-D-glucan | - | - | - | - | 1件: 97 97 💬
|
250 | Bezlotoxumab | 1件: Bezlotoxumab Bezlotoxumab | 1件: Bezlotoxumab
Bezlotoxumab
💬
| - | - | 2件: 96 96, 97 💬
|
251 | BG9924 | - | - | - | - | 2件: 46 46, 97 💬
|
252 | BGP-014 | - | - | - | - | 1件: 97 97 💬
|
253 | BGP-014 capsules | - | - | - | - | 1件: 97 97 💬
|
254 | BI 655130 | - | - | - | - | 3件: 37 37, 96, 97 💬
|
255 | BI-peglyte | - | - | - | - | 2件: 96 96, 97 💬
|
256 | Biap | - | - | - | - | 2件: 46 46, 97 💬
|
257 | Bicarbonato DI sodio | - | - | - | - | 1件: 97 97 💬
|
258 | Bifidobacterium | 1件: Bifidobacterium spp. Bifidobacterium spp. | 1件: Bifidobacterium
Bifidobacterium
💬
| - | - | 6件: 6 6, 35, 67, 96, 97, 271 💬
|
259 | Bifidobacterium breve | 2件: Bifidobacterium breve Bifidobacterium breve, Bifidobacterium spp. | 1件: Bifidobacterium
Bifidobacterium
💬
| - | - | 1件: 97 97 💬
|
260 | Bifidobacterium infantis 35624 | 2件: Bifidobacterium longum infantis Bifidobacterium longum infantis, Bifidobacterium spp. | 1件: Bifidobacterium
Bifidobacterium
💬
| - | - | 2件: 96 96, 97 💬
|
261 | Bifidobacterium longum | 2件: Bifidobacterium longum Bifidobacterium longum, Bifidobacterium spp. | 1件: Bifidobacterium
Bifidobacterium
💬
| - | - | 1件: 97 97 💬
|
262 | Bimekizumab | 1件: Bimekizumab Bimekizumab | 1件: Bimekizumab
Bimekizumab
💬
| 2件: IL17A IL17A, IL17F 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 5件: 37 37, 46, 97, 107, 271 💬
|
263 | BIO-enhanced curcumin soft gelatin capsule | - | - | - | - | 1件: 97 97 💬
|
264 | Biological drug | - | - | - | - | 4件: 46 46, 96, 97, 107 💬
|
265 | Biological sampling | - | - | - | - | 2件: 65 65, 97 💬
|
266 | Biologically active human fecal material, openbiome | - | - | - | - | 1件: 97 97 💬
|
267 | Biologically active human fecal microbiota | - | - | - | - | 1件: 97 97 💬
|
268 | Biologics | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
269 | Biopsy OF colon | - | - | - | - | 1件: 97 97 💬
|
270 | Biosimilar | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
271 | Biosimilar infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
272 | Biospecimen collection | - | - | - | - | 18件: 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
273 | Bisacodyl | 1件: Bisacodyl Bisacodyl | 1件: Bisacodyl
Bisacodyl
💬
| - | - | 2件: 13 13, 97 💬
|
274 | Bitter candytuft fresh plant extract | - | - | - | - | 1件: 97 97 💬
|
275 | Bitterschleifenblume-ganzpflanze 1,5ML/10ML | - | - | - | - | 1件: 97 97 💬
|
276 | BL-7040 | - | - | - | - | 1件: 97 97 💬
|
277 | Blood and fecal samples | - | - | - | - | 2件: 96 96, 97 💬
|
278 | Blood or saliva sample collection | - | - | - | - | 3件: 96 96, 97, 299 💬
|
279 | Blood sample | - | - | - | - | 28件: 2 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
|
280 | Blood samples | - | - | - | - | 12件: 13 13, 41, 46, 51, 61, 96, 97, 167, 227, 240, 271, 280 💬
|
281 | Blood sampling, endoscopy | - | - | - | - | 1件: 97 97 💬
|
282 | Blood test 4 edta tubes | - | - | - | - | 1件: 97 97 💬
|
283 | Blueberry-rich diet | 1件: Blueberry Blueberry | - | - | - | 2件: 96 96, 97 💬
|
284 | BMS-188667 | - | - | - | - | 10件: 46 46, 49, 53, 65, 96, 97, 107, 160, 222, 271 💬
|
285 | BMS-936557 | - | - | - | - | 2件: 96 96, 97 💬
|
286 | BMS-986165 | - | - | - | - | 3件: 49 49, 96, 97 💬
|
287 | BMS-986166 | - | - | - | - | 1件: 97 97 💬
|
288 | BMS-986184 | - | - | - | - | 1件: 97 97 💬
|
289 | BMS986165 | - | - | - | - | 2件: 96 96, 97 💬
|
290 | Boulardii | - | - | - | - | 2件: 96 96, 97 💬
|
291 | Brazikumab | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
292 | Brazikumab induction dose | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
293 | Brazikumab maintenance dose | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
294 | Breast milk sampling | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
295 | Brepocitinib 25 MG | - | - | - | - | 2件: 96 96, 97 💬
|
296 | Brepocitinib 5 MG | - | - | - | - | 2件: 96 96, 97 💬
|
297 | Broccoli | 1件: Broccoli Broccoli | - | - | - | 1件: 97 97 💬
|
298 | Bromlein | - | - | - | - | 2件: 94 94, 97 💬
|
299 | BRS201 | - | - | - | - | 2件: 94 94, 97 💬
|
300 | BT-11 | - | - | - | - | 2件: 96 96, 97 💬
|
301 | BT-11 1000MG | - | - | - | - | 2件: 96 96, 97 💬
|
302 | BT-11 500 MG | - | - | - | - | 2件: 96 96, 97 💬
|
303 | BT051 200 MG | - | - | - | - | 1件: 97 97 💬
|
304 | BT051 3200 MG | - | - | - | - | 1件: 97 97 💬
|
305 | BT051 800 MG | - | - | - | - | 1件: 97 97 💬
|
306 | Budenofalk 2MG rectal foam | - | - | - | - | 1件: 97 97 💬
|
307 | Budenofalk 3MG | - | - | - | - | 1件: 97 97 💬
|
308 | Budenofalk rectal foam | - | - | - | - | 1件: 97 97 💬
|
309 | Budenofalk® suppositories | - | - | - | - | 1件: 97 97 💬
|
310 | Budesonide | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 66 66, 93, 94, 95, 96, 97, 98 💬
|
311 | Budesonide MMX | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
312 | Budesonide MMX 6 MG tablet | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
313 | Budesonide MMX® 6 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
314 | Budesonide MMX® 9 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
315 | Budesonide-MMX | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
316 | Budesonide-MMX® 6 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
317 | Budesonide-MMX® 9 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
318 | Bupropion-SR | 1件: Bupropion Bupropion | 3件: Bupropion hydrochloride
Bupropion hydrochloride
,
Bupropion
,
Bupropion hydrobromide
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 97 97 💬
|
319 | Butanoic acid | 1件: Butyric Acid Butyric Acid | 1件: Sodium butyrate
Sodium butyrate
💬
| - | - | 1件: 97 97 💬
|
320 | Butyrate | 1件: Butyric Acid Butyric Acid | 1件: Sodium butyrate
Sodium butyrate
💬
| - | - | 2件: 46 46, 97 💬
|
321 | BY demand | - | - | - | - | 2件: 96 96, 97 💬
|
322 | Cacit D3 effervescent granules, 500 MG/440 IU | - | - | - | - | 1件: 97 97 💬
|
323 | Caffeine | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 2 2, 6, 13, 21, 46, 96, 97, 265 💬
|
324 | Caffeine 100 MG | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 96 96, 97 💬
|
325 | Calcio | 1件: Calcium Calcium | - | - | - | 3件: 13 13, 96, 97 💬
|
326 | Calcium | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 12件: 6 6, 46, 49, 68, 93, 95, 97, 156, 222, 235, 271, 274 💬
|
327 | Calcium carbonate 600 MG once daily | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 97 97 💬
|
328 | Calprotectin | - | - | - | - | 1件: 97 97 💬
|
329 | Caltrate | - | - | - | - | 1件: 97 97 💬
|
330 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 19, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 271 💬
|
331 | Cannabis, medical | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 5件: 2 2, 6, 13, 96, 97 💬
|
332 | Carbon | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 4件: 6 6, 97, 149, 235 💬
|
333 | Carbon dioxide insufflation | 2件: Activated charcoal Activated charcoal, Carbon dioxide | 2件: Carbon dioxide
Carbon dioxide
,
Charcoal, activated
💬
| - | - | 1件: 97 97 💬
|
334 | Carbon dioxide insufflation during colonoscopy | 2件: Activated charcoal Activated charcoal, Carbon dioxide | 2件: Carbon dioxide
Carbon dioxide
,
Charcoal, activated
💬
| - | - | 1件: 97 97 💬
|
335 | Carbossimaltosio ferrico | - | - | - | - | 1件: 97 97 💬
|
336 | Carotegrast methyl | 1件: Carotegrast methyl Carotegrast methyl | 1件: Carotegrast methyl
Carotegrast methyl
💬
| 3件: ITGA4 ITGA4, ITGB1, ITGB7 💬
| 30件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagosome, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Transcriptional misregulation in cancer, Virion - Rotavirus, Yersinia infection 💬 | 1件: 97 97 💬
|
337 | Carvi extractum fluidum | - | - | - | - | 1件: 97 97 💬
|
338 | Casein | 1件: Casein Casein | - | - | - | 1件: 97 97 💬
|
339 | CAT-354 | - | - | - | - | 1件: 97 97 💬
|
340 | Catridecacog | 1件: Catridecacog Catridecacog | 1件: Catridecacog
Catridecacog
💬
| - | - | 2件: 97 97, 288 💬
|
341 | CB-01-02 | - | - | - | - | 1件: 97 97 💬
|
342 | CB-01-05-MMX | - | - | - | - | 1件: 97 97 💬
|
343 | CBD, synthetic form | - | - | - | - | 1件: 97 97 💬
|
344 | CBP-307 | - | - | - | - | 1件: 97 97 💬
|
345 | CC-10004 | - | - | - | - | 5件: 46 46, 56, 97, 162, 271 💬
|
346 | CD7 CAR T-cells | - | - | - | - | 3件: 50 50, 96, 97 💬
|
347 | Cded (crohn'S disease exclusion diet) IN addition TO ANTI-TNF therapy | - | - | - | - | 2件: 96 96, 97 💬
|
348 | Ceftriaxone | 1件: Ceftriaxone Ceftriaxone | 2件: Ceftriaxone sodium
Ceftriaxone sodium
,
Ceftriaxone
💬
| - | - | 3件: 2 2, 6, 97 💬
|
349 | Cefuroxime | 1件: Cefuroxime Cefuroxime | 3件: Cefuroxime
Cefuroxime
,
Cefuroxime axetil
,
Cefuroxime sodium
💬
| - | - | 2件: 97 97, 299 💬
|
350 | Celecoxib | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 13件: 2 2, 3, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
351 | Cgmp protein | - | - | - | - | 1件: 97 97 💬
|
352 | Chloride | 1件: Chloride ion Chloride ion | - | - | - | 1件: 97 97 💬
|
353 | Chlorogenic acid | 1件: Chlorogenic Acid Chlorogenic Acid | - | - | - | 1件: 97 97 💬
|
354 | Cholecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
|
355 | Chronic- PF-06480605 150 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
356 | Chronic- PF-06480605 450 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
357 | Chronic- PF-06480605 50 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
358 | Ciclosporin | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 12件: 26 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 269 💬
|
359 | Ciclosporina | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 49 49, 60, 97 💬
|
360 | Cimzia | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 6件: 46 46, 49, 96, 97, 107, 271 💬
|
361 | Ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 6件: 2 2, 46, 60, 96, 97, 299 💬
|
362 | CLA | - | - | - | - | 2件: 13 13, 97 💬
|
363 | Clarithromycin | 1件: Clarithromycin Clarithromycin | 1件: Clarithromycin
Clarithromycin
💬
| - | - | 8件: 6 6, 46, 63, 84, 96, 97, 228, 299 💬
|
364 | Clipper | - | - | - | - | 1件: 97 97 💬
|
365 | Cloruro DI potassio | - | - | - | - | 1件: 97 97 💬
|
366 | Cloruro DI sodio | - | - | - | - | 1件: 97 97 💬
|
367 | Clotrimazole | 1件: Clotrimazole Clotrimazole | 1件: Clotrimazole
Clotrimazole
💬
| - | - | 1件: 97 97 💬
|
368 | CMTS0929 | - | - | - | - | 1件: 97 97 💬
|
369 | Cnto 148 | - | - | - | - | 4件: 46 46, 84, 97, 271 💬
|
370 | CNTO-148 | - | - | - | - | 1件: 97 97 💬
|
371 | CNTO1275 | - | - | - | - | 6件: 46 46, 49, 84, 93, 96, 97 💬
|
372 | CNTO148 | - | - | - | - | 5件: 46 46, 84, 96, 97, 107 💬
|
373 | CNTO1959 | - | - | - | - | 4件: 37 37, 41, 96, 97 💬
|
374 | CNTO312 | - | - | - | - | 1件: 97 97 💬
|
375 | CO-transplantation OF FMT and pectin | - | - | - | - | 1件: 97 97 💬
|
376 | Coamoxiclav | - | - | - | - | 1件: 97 97 💬
|
377 | Cobitolimod | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
378 | Cobitolimod 250 MG | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
379 | Cobitolimod 500 MG | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
380 | Cobitolimod 500MG | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
381 | Coffee coal | - | - | - | - | 1件: 97 97 💬
|
382 | Colal pred | - | - | - | - | 1件: 97 97 💬
|
383 | Colal-pred | - | - | - | - | 1件: 97 97 💬
|
384 | Colchicine | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 8件: 42 42, 46, 50, 56, 93, 97, 210, 266 💬
|
385 | Colecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 13 13, 46, 96, 97, 228 💬
|
386 | Colectomy | - | - | - | - | 1件: 97 97 💬
|
387 | Colon KCC heptapeptide | - | - | - | - | 1件: 97 97 💬
|
388 | Colon preparation FOR colonoscopy | - | - | - | - | 1件: 97 97 💬
|
389 | Colonoscopy | - | - | - | - | 2件: 96 96, 97 💬
|
390 | Colonoscopy with indigo-carmine chromoendoscopy | - | - | - | - | 1件: 97 97 💬
|
391 | Colorectal biopsies | - | - | - | - | 1件: 97 97 💬
|
392 | Colored water | - | - | - | - | 1件: 97 97 💬
|
393 | Coltect | - | - | - | - | 1件: 97 97 💬
|
394 | Combination oral budesonide and rectal hydrocortisone | - | - | - | - | 1件: 97 97 💬
|
395 | Companion diagnostic (CDX) testing | - | - | - | - | 1件: 97 97 💬
|
396 | Compressed oxygen | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 1件: 97 97 💬
|
397 | Control diet | - | - | - | - | 2件: 96 96, 97 💬
|
398 | Control group: mesalazine enema treatment | - | - | - | - | 1件: 97 97 💬
|
399 | Conventional drugs | - | - | - | - | 1件: 97 97 💬
|
400 | Conventional IBD medical treatment | - | - | - | - | 1件: 97 97 💬
|
401 | Conventional therapy | - | - | - | - | 5件: 6 6, 49, 67, 97, 222 💬
|
402 | Conventional treatment | - | - | - | - | 2件: 96 96, 97 💬
|
403 | Conventional white-light colonoscopy | - | - | - | - | 1件: 97 97 💬
|
404 | Coolonic biopsies | - | - | - | - | 2件: 96 96, 97 💬
|
405 | Corn starch | 1件: Starch, corn Starch, corn | 1件: Corn starch
Corn starch
💬
| - | - | 2件: 49 49, 97 💬
|
406 | Corticosteroid | - | - | - | - | 7件: 13 13, 66, 84, 96, 97, 113, 222 💬
|
407 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
|
408 | Corticosteroids only | - | - | - | - | 1件: 97 97 💬
|
409 | Cortimentmmx 9 MG | - | - | - | - | 1件: 97 97 💬
|
410 | Cosmofer | - | - | - | - | 2件: 96 96, 97 💬
|
411 | Cosmofer 50MG/ML solution FOR infusion or injection | - | - | - | - | 2件: 96 96, 97 💬
|
412 | Cotrimoxazole | - | - | - | - | 2件: 85 85, 97 💬
|
413 | Covid-19 vaccine | - | - | - | - | 5件: 13 13, 46, 49, 51, 97 💬
|
414 | Covid-19 vaccines AT A 3-month interval | - | - | - | - | 2件: 46 46, 97 💬
|
415 | Covid-19 vaccines AT A 6-month interval | - | - | - | - | 2件: 46 46, 97 💬
|
416 | CP- 690 550 | - | - | - | - | 1件: 97 97 💬
|
417 | CP-101 | - | - | - | - | 1件: 97 97 💬
|
418 | CP-690,500 5 MG | - | - | - | - | 1件: 97 97 💬
|
419 | CP-690,550 | - | - | - | - | 4件: 46 46, 96, 97, 107 💬
|
420 | CP-690,550 10 MG | - | - | - | - | 1件: 97 97 💬
|
421 | CP-690,550-10 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
422 | CP690,550 | - | - | - | - | 2件: 46 46, 97 💬
|
423 | Creatine monohydrate | 1件: Creatine Creatine | - | - | - | 5件: 2 2, 8, 97, 113, 156 💬
|
424 | Crohn'S disease | - | - | - | - | 3件: 56 56, 96, 97 💬
|
425 | CS (corticosteroids) only | - | - | - | - | 1件: 97 97 💬
|
426 | CT-P13 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
427 | CU104 | - | - | - | - | 1件: 97 97 💬
|
428 | Curcumin | 1件: Curcumin Curcumin | - | - | - | 10件: 13 13, 34, 46, 67, 74, 94, 96, 97, 139, 299 💬
|
429 | Curcumin supplementation | 1件: Curcumin Curcumin | - | - | - | 1件: 97 97 💬
|
430 | Cyclosporin | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 50 50, 54, 60, 63, 97, 107, 222, 274, 326 💬
|
431 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 28件: 11 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
|
432 | Cyclosporine oral product | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 60 60, 97 💬
|
433 | Cyclosporine VS infliximab | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 97 97 💬
|
434 | Cycol | - | - | - | - | 1件: 97 97 💬
|
435 | Cytochrome P450 (CYP) substrates | - | - | - | - | 2件: 96 96, 97 💬
|
436 | D.3.6.2.1 - valore: 45 / 0.45 MG/ML | - | - | - | - | 1件: 97 97 💬
|
437 | Daclizumab | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 💬
|
438 | Dacortin | - | - | - | - | 2件: 97 97, 162 💬
|
439 | Dapagliflozin 10MG TAB | 1件: Dapagliflozin Dapagliflozin | 1件: Dapagliflozin
Dapagliflozin
💬
| - | - | 3件: 19 19, 97, 218 💬
|
440 | Decortin H 1 MG | - | - | - | - | 1件: 97 97 💬
|
441 | Decortin H 10MG | - | - | - | - | 1件: 97 97 💬
|
442 | Decortin H 20MG | - | - | - | - | 1件: 97 97 💬
|
443 | Decortin H 50 MG | - | - | - | - | 1件: 97 97 💬
|
444 | Decortin H 5MG | - | - | - | - | 1件: 97 97 💬
|
445 | Dekavil | - | - | - | - | 2件: 46 46, 97 💬
|
446 | Dekristol | - | - | - | - | 1件: 97 97 💬
|
447 | Delayed and extended release mesalazine | - | - | - | - | 1件: 97 97 💬
|
448 | Deligoparin | - | - | - | - | 1件: 97 97 💬
|
449 | Delmitide acetate | - | - | - | - | 1件: 97 97 💬
|
450 | Deltacortene | - | - | - | - | 2件: 43 43, 97 💬
|
451 | Deltacortene 10 CPR 25MG | - | - | - | - | 1件: 97 97 💬
|
452 | Deltacortene 20 CPR 5MG | - | - | - | - | 1件: 97 97 💬
|
453 | Deltacortene forte*10CPR 25MG | - | - | - | - | 2件: 46 46, 97 💬
|
454 | Deltacortene*20CPR 5MG | - | - | - | - | 3件: 49 49, 97, 113 💬
|
455 | Dersalazina sodica | - | - | - | - | 1件: 97 97 💬
|
456 | Dersalazine sodium | 1件: Dersalazine Dersalazine | - | - | - | 1件: 97 97 💬
|
457 | Deucravacitinib | 1件: Deucravacitinib Deucravacitinib | 1件: Deucravacitinib
Deucravacitinib
💬
| 1件: TYK2 TYK2 💬
| 17件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | 9件: 36 36, 37, 49, 53, 84, 96, 97, 160, 269 💬
|
458 | DEX 21-P | - | - | - | - | 1件: 97 97 💬
|
459 | Dexametasone sodium phosphate | - | - | - | - | 2件: 96 96, 97 💬
|
460 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 19, 28, 35, 63, 64, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
|
461 | Dextran 1 FOR injection | 2件: Dextran Dextran, Dextran 1 | 5件: Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| 2件: LIPC LIPC, LPL 💬
| 4件: Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | 1件: 97 97 💬
|
462 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 6 6, 8, 13, 21, 85, 96, 97, 156 💬
|
463 | Dextromethorphan 30 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 96 96, 97 💬
|
464 | Diet 1 | - | - | - | - | 2件: 96 96, 97 💬
|
465 | Diet 2 | - | - | - | - | 2件: 96 96, 97 💬
|
466 | Dietary fiber mixture | - | - | - | - | 1件: 97 97 💬
|
467 | Dietary intervention with NO-carrageenan diet | - | - | - | - | 1件: 97 97 💬
|
468 | Dietary therapy | - | - | - | - | 2件: 96 96, 97 💬
|
469 | Dificlir 200 MG compresse rivestite CON film | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
470 | Dificlir 200 MG FILM-coated tablets | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
471 | DIMS0150 | - | - | - | - | 1件: 97 97 💬
|
472 | Diosmin | 1件: Diosmin Diosmin | 1件: Diosmin
Diosmin
💬
| - | - | 3件: 51 51, 97, 265 💬
|
473 | Diphtheria booster vaccination | - | - | - | - | 1件: 97 97 💬
|
474 | Doxycycline | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 13件: 23 23, 28, 34, 46, 84, 89, 96, 97, 158, 161, 162, 280, 299 💬
|
475 | Dried chicory root | - | - | - | - | 1件: 97 97 💬
|
476 | Dual biological therapy | - | - | - | - | 1件: 97 97 💬
|
477 | Dupilumab | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 5件: 51 51, 97, 98, 160, 162 💬
|
478 | E-monitoring | - | - | - | - | 1件: 97 97 💬
|
479 | E. coli nissle | - | - | - | - | 1件: 97 97 💬
|
480 | E400 elimination | - | - | - | - | 1件: 97 97 💬
|
481 | E6007 | - | - | - | - | 1件: 97 97 💬
|
482 | E6011 | - | - | - | - | 4件: 46 46, 93, 96, 97 💬
|
483 | Ebetrex 15 MG = 0,75 ML, oplossing voor injectie IN voorgevulde injectiespuit 20 MG/ML | - | - | - | - | 2件: 96 96, 97 💬
|
484 | Echinacea extract | 1件: Echinacea Echinacea | - | - | - | 1件: 97 97 💬
|
485 | Ecologic 825 | - | - | - | - | 1件: 97 97 💬
|
486 | Efavaleukin alfa | 1件: Efavaleukin alfa Efavaleukin alfa | 1件: Efavaleukin alfa
Efavaleukin alfa
💬
| - | - | 2件: 49 49, 97 💬
|
487 | Efmarodocokin alfa | 1件: Efmarodocokin alfa Efmarodocokin alfa | 1件: Efmarodocokin alfa
Efmarodocokin alfa
💬
| 1件: IL22 IL22 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬
|
488 | EGF enema | - | - | - | - | 1件: 97 97 💬
|
489 | Eicosapentaenoic acid | 1件: Icosapent Icosapent | 1件: Icosapent
Icosapent
💬
| - | - | 6件: 49 49, 96, 97, 296, 297, 338 💬
|
490 | Elemental 028 extra | - | - | - | - | 1件: 97 97 💬
|
491 | Eltrekibart | 1件: Eltrekibart Eltrekibart | 1件: Eltrekibart
Eltrekibart
💬
| 1件: CXCR1 CXCR1 💬
| 6件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 97 97 💬
|
492 | Emea/H/C/000240 | - | - | - | - | 2件: 96 96, 97 💬
|
493 | Emea/H/C/000481 | - | - | - | - | 1件: 97 97 💬
|
494 | Emea/H/C/002576 | - | - | - | - | 2件: 96 96, 97 💬
|
495 | Empagliflozin | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬
| - | - | 10件: 65 65, 67, 72, 77, 86, 96, 97, 257, 298, 299 💬
|
496 | Empagliflozin 10 MG | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬
| - | - | 4件: 58 58, 67, 86, 97 💬
|
497 | Encapsulated faecal microbiota filtrate | - | - | - | - | 1件: 97 97 💬
|
498 | Enema | - | - | - | - | 1件: 97 97 💬
|
499 | Engerix-B 20µG / 1ML suspensióN inyectable EN jeringa precargada | - | - | - | - | 1件: 97 97 💬
|
500 | Ensure surgery immunonutrition shakes | - | - | - | - | 1件: 97 97 💬
|
501 | Entecavir | 1件: Entecavir Entecavir | 2件: Entecavir
Entecavir
,
Entecavir
💬
| - | - | 6件: 46 46, 56, 96, 97, 107, 271 💬
|
502 | Enteral nutrition | - | - | - | - | 2件: 96 96, 97 💬
|
503 | Entocort CR | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 96 96, 97 💬
|
504 | Entocort EC® 3 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
505 | Entocort® CR | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
506 | Entyvio | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 💬
|
507 | Entyvio - 300 MG - polvere PE rconcentrato PER soluzione PER infu | - | - | - | - | 1件: 97 97 💬
|
508 | Entyvio 300 MG | - | - | - | - | 1件: 97 97 💬
|
509 | Entyvio 300MG | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 97 97 💬
|
510 | Epidermal growth factor enema | - | - | - | - | 1件: 97 97 💬
|
511 | Ergocalciferol | 1件: Ergocalciferol Ergocalciferol | 1件: Ergocalciferol
Ergocalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 46 46, 84, 96, 97, 299 💬
|
512 | Esketamine | 1件: Esketamine Esketamine | 2件: Esketamine
Esketamine
,
Esketamine hydrochloride
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 5件: 2 2, 4, 6, 96, 97 💬
|
513 | Ethanol | 1件: Ethanol Ethanol | 3件: Alcohol
Alcohol
,
Isopropanol and methylated alcohol
,
Ethanol
💬
| - | - | 4件: 58 58, 97, 279, 280 💬
|
514 | Etrasimod | 1件: Etrasimod Etrasimod | 2件: Etrasimod
Etrasimod
,
Etrasimod arginine
💬
| 3件: S1PR1 S1PR1, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 96 96, 97, 98 💬
|
515 | Etrasimod L-arginine | 1件: Etrasimod Etrasimod | 2件: Etrasimod
Etrasimod
,
Etrasimod arginine
💬
| 3件: S1PR1 S1PR1, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 96 96, 97, 98 💬
|
516 | Etrolizumab | 1件: Etrolizumab Etrolizumab | 1件: Etrolizumab
Etrolizumab
💬
| 1件: ITGB7 ITGB7 💬
| 12件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬 | 2件: 96 96, 97 💬
|
517 | Etrozulimab | - | - | - | - | 1件: 97 97 💬
|
518 | Evening group | - | - | - | - | 1件: 97 97 💬
|
519 | EX-vivo stimulation OF cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab | - | - | - | - | 1件: 97 97 💬
|
520 | Exercise intervention | - | - | - | - | 4件: 13 13, 18, 60, 97 💬
|
521 | Exoflo | - | - | - | - | 2件: 96 96, 97 💬
|
522 | Exosomes derived from human umbilical cord mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
523 | Exposed TO IBD pharmacotherapy during pregnancy | - | - | - | - | 1件: 97 97 💬
|
524 | Exposure TO golimumab | - | - | - | - | 1件: 97 97 💬
|
525 | Eziclen | - | - | - | - | 1件: 97 97 💬
|
526 | F8il10 | - | - | - | - | 2件: 46 46, 97 💬
|
527 | Factor xiii | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 3件: 51 51, 97, 288 💬
|
528 | Faecal bacterial transplantation | - | - | - | - | 1件: 97 97 💬
|
529 | Faecal matter | - | - | - | - | 1件: 97 97 💬
|
530 | Faecal microbiota transplant | - | - | - | - | 2件: 94 94, 97 💬
|
531 | Faecal microbiota transplantation | - | - | - | - | 5件: 46 46, 84, 96, 97, 271 💬
|
532 | FE 999301 | - | - | - | - | 2件: 96 96, 97 💬
|
533 | Feasibility OF BETA-hydroxybutyrate supplementation TO reduce inflammation IN patients with crohn'S | - | - | - | - | 2件: 96 96, 97 💬
|
534 | Febuxostat | 1件: Febuxostat Febuxostat | 2件: Febuxostat
Febuxostat
,
Febuxostat hydrate
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 4件: 2 2, 6, 13, 97 💬
|
535 | Fecal microbial L transplantation | - | - | - | - | 1件: 97 97 💬
|
536 | Fecal microbial transplant | - | - | - | - | 3件: 46 46, 96, 97 💬
|
537 | Fecal microbial transplantation | - | - | - | - | 2件: 96 96, 97 💬
|
538 | Fecal microbiota | 1件: Fecal microbiota Fecal microbiota | - | - | - | 5件: 13 13, 49, 93, 96, 97 💬
|
539 | Fecal microbiota capsule | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
540 | Fecal microbiota enema | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
541 | Fecal microbiota transplant | 1件: Fecal microbiota Fecal microbiota | - | - | - | 3件: 6 6, 96, 97 💬
|
542 | Fecal microbiota transplantation | 1件: Fecal microbiota Fecal microbiota | - | - | - | 10件: 2 2, 6, 13, 63, 66, 94, 96, 97, 99, 271 💬
|
543 | Fecal microbiota transplantation (FMT), openbiome | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
544 | Fecal microbiota transplantation BY intra-rectal enemas | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
545 | Fecal microbiota transplantation BY stool capsules | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
546 | Fecal microbiota transplantation capsules | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
547 | Fecal transplantation | - | - | - | - | 1件: 97 97 💬
|
548 | Fendrix, suspensióN inyectable | - | - | - | - | 1件: 97 97 💬
|
549 | Fenofibrate | 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate
Fenofibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 6件: 8 8, 79, 93, 94, 97, 265 💬
|
550 | Fenofibrate 160MG | 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate
Fenofibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 97 97 💬
|
551 | Fentanyl | 1件: Fentanyl Fentanyl | 3件: Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 5件: 46 46, 70, 97, 231, 298 💬
|
552 | Fentanyl B. braun | 1件: Fentanyl Fentanyl | 3件: Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
553 | Feraccru | 1件: Ferric maltol Ferric maltol | 1件: Ferric maltol
Ferric maltol
💬
| - | - | 1件: 97 97 💬
|
554 | Feramyl | - | - | - | - | 1件: 97 97 💬
|
555 | Ferinject | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 3件: 86 86, 97, 299 💬
|
556 | Ferinject - 50 MG/ML soluzione iniettabile O PER infusione 1 flaconcino IN vetro DA 10 ML | - | - | - | - | 1件: 97 97 💬
|
557 | Ferinject 50 MG /ML. solucióN inyectable Y para perfusióN | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
558 | Ferinject 50 MG eisen/ML | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
559 | Ferinject 50 MG iron/ML solution FOR injection and infusion | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
560 | Ferlixit - 62.5 MG/5 ML soluzione PER USO orale E USO endovenoso 5 fiale DA 5 ML | - | - | - | - | 1件: 97 97 💬
|
561 | Ferracru | - | - | - | - | 1件: 97 97 💬
|
562 | Ferric carboxy maltose | - | - | - | - | 2件: 96 96, 97 💬
|
563 | Ferric carboxymaltose | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 4件: 86 86, 96, 97, 299 💬
|
564 | Ferric derisomaltose | 1件: Ferric derisomaltose Ferric derisomaltose | 1件: Ferric derisomaltose
Ferric derisomaltose
💬
| - | - | 1件: 97 97 💬
|
565 | Ferric gluconate | 1件: Ferrous gluconate Ferrous gluconate | 2件: Ferric gluconate
Ferric gluconate
,
Ferrous gluconate
💬
| - | - | 1件: 97 97 💬
|
566 | Ferric maltol | 1件: Ferric maltol Ferric maltol | 1件: Ferric maltol
Ferric maltol
💬
| - | - | 2件: 96 96, 97 💬
|
567 | Ferric trimaltol | - | - | - | - | 1件: 97 97 💬
|
568 | Ferrisat | - | - | - | - | 1件: 97 97 💬
|
569 | Ferrisat 50MG/ML | - | - | - | - | 1件: 97 97 💬
|
570 | Ferro duretter, prolonged release tablet | - | - | - | - | 1件: 97 97 💬
|
571 | Ferro E.V. (come carbossimaltoso ferrico) - ferinject | - | - | - | - | 1件: 97 97 💬
|
572 | Ferrofumaraat apotex | - | - | - | - | 1件: 97 97 💬
|
573 | Ferrofumaraat teva | - | - | - | - | 1件: 97 97 💬
|
574 | Ferrous fumarate | 1件: Ferrous fumarate Ferrous fumarate | - | - | - | 1件: 97 97 💬
|
575 | Ferrous fumarate syrup | 1件: Ferrous fumarate Ferrous fumarate | - | - | - | 1件: 97 97 💬
|
576 | Ferrous sulfate tablets | - | - | - | - | 1件: 97 97 💬
|
577 | Ferrous sulphate | - | - | - | - | 2件: 96 96, 97 💬
|
578 | Ferrous sulphate with 65 MG iron++ PER tablet | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
579 | Fibrin adhesive | 1件: Fibrin Fibrin | - | - | - | 1件: 97 97 💬
|
580 | Fidaxomicin | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
581 | Fidaxomicina | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
582 | Filgotinib | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 10件: 46 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
|
583 | Filgotinib maleate | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬
|
584 | FILM-coated tablet | - | - | - | - | 2件: 96 96, 97 💬
|
585 | First-line biologic:IFX | - | - | - | - | 1件: 97 97 💬
|
586 | First-line biologic:VDZ | - | - | - | - | 1件: 97 97 💬
|
587 | FITC-adalimumab | - | - | - | - | 2件: 96 96, 97 💬
|
588 | Flagyl | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 2件: 96 96, 97 💬
|
589 | Flixabi | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
590 | Fluorescein | 1件: Fluorescein Fluorescein | 2件: Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | 2件: 22 22, 97 💬
|
591 | Fluorescence imaging | - | - | - | - | 2件: 46 46, 97 💬
|
592 | Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration OF unlabeled vedolizumab | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
593 | Fluorescence molecular imaging procedure without prior administration OF vedolizumab-800CW | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
594 | Flupentixol | 1件: Flupentixol Flupentixol | 3件: Flupentixol
Flupentixol
,
Flupentixol dihydrochloride
,
Flupentixol decanoate
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 97 97 💬
|
595 | FMT | - | - | - | - | 3件: 96 96, 97, 271 💬
|
596 | FMT enema | - | - | - | - | 1件: 97 97 💬
|
597 | FMT infusions | - | - | - | - | 1件: 97 97 💬
|
598 | FMT oral | - | - | - | - | 1件: 97 97 💬
|
599 | FMT protocol | - | - | - | - | 1件: 97 97 💬
|
600 | Folacin | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 2件: 96 96, 97 💬
|
601 | Folic acid | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 6件: 46 46, 84, 96, 97, 172, 296 💬
|
602 | Fosfomycin | 1件: Fosfomycin Fosfomycin | 3件: Fosfomycin tromethamine
Fosfomycin tromethamine
,
Fosfomycin sodium
,
Fosfomycin
💬
| - | - | 2件: 96 96, 97 💬
|
603 | FP-110 | - | - | - | - | 1件: 97 97 💬
|
604 | FP-CYA-050 | - | - | - | - | 1件: 97 97 💬
|
605 | FP-CYA-053 | - | - | - | - | 1件: 97 97 💬
|
606 | Free diet | - | - | - | - | 1件: 97 97 💬
|
607 | Freeze dried grape powder | - | - | - | - | 2件: 96 96, 97 💬
|
608 | Freeze-dried black raspberry powder | - | - | - | - | 1件: 97 97 💬
|
609 | Frondanol | - | - | - | - | 1件: 97 97 💬
|
610 | Fructose sachet | 1件: Fructose Fructose | 1件: Fructose
Fructose
💬
| - | - | 1件: 97 97 💬
|
611 | Fully human IGG1 monoclonal antibody specific FOR TL1A | - | - | - | - | 2件: 96 96, 97 💬
|
612 | G1567970 | - | - | - | - | 3件: 46 46, 53, 97 💬
|
613 | G321605 | - | - | - | - | 3件: 85 85, 96, 97 💬
|
614 | Ganciclovir | 1件: Ganciclovir Ganciclovir | 2件: Ganciclovir
Ganciclovir
,
Ganciclovir sodium
💬
| - | - | 3件: 28 28, 60, 97 💬
|
615 | Gardasil vaccine | - | - | - | - | 1件: 97 97 💬
|
616 | Gastro-resistant phosphatidylcholine granules | - | - | - | - | 1件: 97 97 💬
|
617 | Gastroscopy | - | - | - | - | 1件: 97 97 💬
|
618 | GB004 | - | - | - | - | 1件: 97 97 💬
|
619 | GB004-HCL | - | - | - | - | 1件: 97 97 💬
|
620 | GED-0301 | - | - | - | - | 2件: 96 96, 97 💬
|
621 | GED-0507-34-levo | 1件: GED-0507-34-Levo GED-0507-34-Levo | - | - | - | 1件: 97 97 💬
|
622 | GED-0507-34-levo 160 MG | 1件: GED-0507-34-Levo GED-0507-34-Levo | - | - | - | 1件: 97 97 💬
|
623 | GED-0507-34-levo 80 MG | 1件: GED-0507-34-Levo GED-0507-34-Levo | - | - | - | 1件: 97 97 💬
|
624 | GED0507 | - | - | - | - | 1件: 97 97 💬
|
625 | Genomic DNA | - | - | - | - | 1件: 97 97 💬
|
626 | GI-270384 | - | - | - | - | 1件: 97 97 💬
|
627 | Globifer forte | - | - | - | - | 1件: 97 97 💬
|
628 | GLPG0634 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
629 | GLPG0974 | - | - | - | - | 1件: 97 97 💬
|
630 | GLPG1205 | - | - | - | - | 3件: 85 85, 96, 97 💬
|
631 | GLPG3970 | - | - | - | - | 3件: 46 46, 53, 97 💬
|
632 | Gluconato ferrico sodico | - | - | - | - | 1件: 97 97 💬
|
633 | Glucose | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 9件: 6 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
|
634 | Glucose-based sports drink | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 1件: 97 97 💬
|
635 | Glutamine | 1件: L-Glutamine L-Glutamine | 1件: Glutamine
Glutamine
💬
| - | - | 10件: 87 87, 89, 96, 97, 113, 214, 215, 222, 245, 299 💬
|
636 | Gluten free diet | - | - | - | - | 1件: 97 97 💬
|
637 | Gluten-free diet | - | - | - | - | 2件: 94 94, 97 💬
|
638 | Glycyrrhiza glabra root | 1件: Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | 1件: 97 97 💬
|
639 | GM-CSF, fosfomycin and metronidazole | - | - | - | - | 1件: 97 97 💬
|
640 | Golimumab | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 💬
|
641 | Golimumab 1 MG PER KG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
642 | Golimumab 100 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
643 | Golimumab 2 MG PER KG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
644 | Golimumab 200 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
645 | Golimumab 4 MG PER KG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
646 | Golimumab 400 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
647 | Golimumab 50 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
648 | Golimumab 50 MG IN patients <80 KG and golimumab 100 MG IN patients >80 KG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
649 | Golimumab dose 1 | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
650 | Golimumab dose 2 | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
651 | Golimumab liquid IN prefilled syringe | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 84, 97, 107 💬
|
652 | Golimumab liquid IN vial | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 97, 271 💬
|
653 | Golimumab prefilled syringe | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
654 | Golimumab trough levels | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
655 | Gralise | - | - | - | - | 2件: 97 97, 226 💬
|
656 | Granocyte 34 | - | - | - | - | 1件: 97 97 💬
|
657 | Granulated mesalamine | - | - | - | - | 1件: 97 97 💬
|
658 | Grape seed extracts | 1件: Grape Grape | - | - | - | 1件: 97 97 💬
|
659 | Grapefruit | 1件: Grapefruit Grapefruit | - | - | - | 4件: 6 6, 46, 50, 97 💬
|
660 | Group 1 OF patients will receive adalimumab while group 1 will receive ustekinumab | - | - | - | - | 1件: 97 97 💬
|
661 | Group 1- control diet | - | - | - | - | 1件: 97 97 💬
|
662 | Group 2 ustekinumab 130 MG | - | - | - | - | 2件: 96 96, 97 💬
|
663 | Group 2- UCD diet | - | - | - | - | 1件: 97 97 💬
|
664 | Group 3: ustekinumab approximately 6 MG/KG | - | - | - | - | 2件: 96 96, 97 💬
|
665 | Growth hormone | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 16件: 2 2, 19, 46, 77, 78, 96, 97, 107, 113, 156, 191, 193, 195, 238, 265, 299 💬
|
666 | GS-1427 | - | - | - | - | 1件: 97 97 💬
|
667 | GS-4875 | - | - | - | - | 1件: 97 97 💬
|
668 | GS-5745 | 1件: GS-5745 GS-5745 | - | - | - | 4件: 46 46, 96, 97, 299 💬
|
669 | GS-5745 IV | 1件: GS-5745 GS-5745 | - | - | - | 1件: 97 97 💬
|
670 | GS-5745 SC | 1件: GS-5745 GS-5745 | - | - | - | 1件: 97 97 💬
|
671 | GS-6034 | - | - | - | - | 4件: 46 46, 53, 96, 97 💬
|
672 | GSK1399686 | - | - | - | - | 1件: 97 97 💬
|
673 | GSK1605786 | - | - | - | - | 2件: 96 96, 97 💬
|
674 | GSK1605786A | - | - | - | - | 2件: 96 96, 97 💬
|
675 | GSK2586184 400MG | - | - | - | - | 1件: 97 97 💬
|
676 | GSK2831781 | - | - | - | - | 1件: 97 97 💬
|
677 | GSK2831781 - double blind phase | - | - | - | - | 1件: 97 97 💬
|
678 | GSK2831781 - open label phase | - | - | - | - | 1件: 97 97 💬
|
679 | GSK2982772 | - | - | - | - | 2件: 46 46, 97 💬
|
680 | GSK2982772A, where A denotes THE free base | - | - | - | - | 2件: 46 46, 97 💬
|
681 | Guaiazulene | 1件: Guaiazulen Guaiazulen | 1件: 1,4-Dimethyl-7-isopropylazulene
1,4-Dimethyl-7-isopropylazulene
💬
| - | - | 1件: 97 97 💬
|
682 | Guselkum | - | - | - | - | 1件: 97 97 💬
|
683 | Guselkumab | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 6件: 37 37, 41, 96, 97, 161, 269 💬
|
684 | Guselkumab dose 1 | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 51 51, 96, 97 💬
|
685 | Guselkumab dose 2 | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 51 51, 96, 97 💬
|
686 | Guselkumab dose 3 | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
687 | Guselkumab intravenous | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 97 97 💬
|
688 | Guselkumab subcutaneous | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 97 97 💬
|
689 | GUT microbial transplantation | - | - | - | - | 1件: 97 97 💬
|
690 | GWP42003 | - | - | - | - | 1件: 97 97 💬
|
691 | H021 | - | - | - | - | 1件: 97 97 💬
|
692 | H02AB | - | - | - | - | 1件: 97 97 💬
|
693 | Haemoglobin | 1件: Hemoglobin Hemoglobin | - | - | - | 1件: 97 97 💬
|
694 | HE3286 | 1件: HE3286 HE3286 | - | - | - | 2件: 46 46, 97 💬
|
695 | Hemay005 tablets | - | - | - | - | 1件: 97 97 💬
|
696 | Hemay007 | - | - | - | - | 1件: 97 97 💬
|
697 | Hepatitis A vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 3件: 46 46, 96, 97 💬
|
698 | Hepatitis B vaccine | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 2件: 46 46, 97 💬
|
699 | Hextend | - | - | - | - | 2件: 96 96, 97 💬
|
700 | HF2 | - | - | - | - | 1件: 97 97 💬
|
701 | HGD40 | - | - | - | - | 1件: 97 97 💬
|
702 | HGS1025 | - | - | - | - | 1件: 97 97 💬
|
703 | High dose | - | - | - | - | 1件: 97 97 💬
|
704 | High dose budesonide | - | - | - | - | 1件: 97 97 💬
|
705 | High dose budesonide rectal foam | - | - | - | - | 1件: 97 97 💬
|
706 | High dose MT-1303 | - | - | - | - | 1件: 97 97 💬
|
707 | High gluten diet | - | - | - | - | 1件: 97 97 💬
|
708 | High protein and LOW fiber diet | - | - | - | - | 1件: 97 97 💬
|
709 | HIGH-dose CICR-NAM | - | - | - | - | 1件: 97 97 💬
|
710 | Histology | - | - | - | - | 1件: 97 97 💬
|
711 | Hladqa1*05A>G screening | - | - | - | - | 2件: 96 96, 97 💬
|
712 | HM201 | - | - | - | - | 2件: 96 96, 97 💬
|
713 | HMPL-004 | - | - | - | - | 2件: 96 96, 97 💬
|
714 | HMPL-004 1800 MG/DAY | - | - | - | - | 1件: 97 97 💬
|
715 | HMPL-004 2400 MG/DAY | - | - | - | - | 1件: 97 97 💬
|
716 | HMPL-004 high dose | - | - | - | - | 1件: 97 97 💬
|
717 | HMPL-004 LOW dose | - | - | - | - | 1件: 97 97 💬
|
718 | HMPL004-6599 | - | - | - | - | 2件: 96 96, 97 💬
|
719 | HRS-7085 tablets | - | - | - | - | 1件: 97 97 💬
|
720 | Hulio | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
721 | HUM291 | - | - | - | - | 2件: 96 96, 97 💬
|
722 | Human ANTI-IP10 monoclonal antibody | - | - | - | - | 2件: 96 96, 97 💬
|
723 | Human ANTI-TNF IGG1 monoclonal antibody | - | - | - | - | 2件: 46 46, 97 💬
|
724 | Human ANTI-TNF-alpha monoclonal antibody | - | - | - | - | 3件: 46 46, 97, 107 💬
|
725 | Human ANTI-tnfalfa | - | - | - | - | 3件: 46 46, 97, 271 💬
|
726 | Human papillomavirus vaccine | - | - | - | - | 1件: 97 97 💬
|
727 | Humanized recombinant IGG4 monoclonal antibody against CD-127 | - | - | - | - | 1件: 97 97 💬
|
728 | Humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 9件: 46 46, 56, 84, 96, 97, 107, 160, 269, 271 💬
|
729 | Humira - 40 MG soluzione iniettabile USO sottocutaneo 1 siringa preriempita 0.8 ML + 1 tampone imbevuto DI alcol IN UN blister | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 56 56, 97 💬
|
730 | Humira 40 MG solution FOR injection IN PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
731 | Humira 40 MG solution FOR injection IN PRE-filled syringes | - | - | - | - | 1件: 97 97 💬
|
732 | Humira 40 MG/0.8 ML solution FOR injection | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 💬
|
733 | Humira 40 MG/0.8 ML solution FOR injection FOR paediatric USE | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
734 | Humira 40MG solution FOR injection | - | - | - | - | 2件: 96 96, 97 💬
|
735 | Humira 40MG/0.4ML PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
736 | Hydrocortisone | 2件: Hydrocortisone Hydrocortisone, Hydrocortisone acetate | 2件: Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 8件: 41 41, 53, 75, 78, 81, 83, 97, 299 💬
|
737 | Hydrogen | 1件: Hydrogen Hydrogen | - | - | - | 6件: 5 5, 6, 17, 97, 226, 288 💬
|
738 | Hydroxocobalamin with butyrate | 2件: Butyric Acid Butyric Acid, Hydroxocobalamin | 3件: Hydroxocobalamin
Hydroxocobalamin
,
Hydroxocobalamin acetate
,
Sodium butyrate
💬
| - | - | 1件: 97 97 💬
|
739 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 26件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
|
740 | Hyperbaric oxygen | - | - | - | - | 4件: 46 46, 96, 97, 269 💬
|
741 | Hyperbaric oxygen therapy | - | - | - | - | 3件: 90 90, 97, 226 💬
|
742 | IBD98-M delayed-release capsules | - | - | - | - | 1件: 97 97 💬
|
743 | Iberogast N | - | - | - | - | 1件: 97 97 💬
|
744 | Identical tacrolimus-free lipid suspension FOR enema | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 97 97 💬
|
745 | Idoform®travel | - | - | - | - | 1件: 97 97 💬
|
746 | IGG2 antibodies | - | - | - | - | 2件: 96 96, 97 💬
|
747 | IM90838 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
748 | Immunotherapy | - | - | - | - | 2件: 96 96, 97 💬
|
749 | Imolope | - | - | - | - | 1件: 97 97 💬
|
750 | Imraldi | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
751 | IMU-838 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
752 | Imuran | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 2件: 96 96, 97 💬
|
753 | Imurek 25MG filmtabletten | - | - | - | - | 1件: 97 97 💬
|
754 | Imurek 50MG filmtabletten | - | - | - | - | 1件: 97 97 💬
|
755 | Imurel | - | - | - | - | 7件: 13 13, 44, 45, 46, 54, 96, 97 💬
|
756 | Inactivated influenza vaccine (IIV) AT baseline | - | - | - | - | 2件: 46 46, 97 💬
|
757 | Inactivated influenza vaccine AT month 1 | - | - | - | - | 2件: 46 46, 97 💬
|
758 | INCB039110 | - | - | - | - | 3件: 51 51, 97, 228 💬
|
759 | Increased dietary intake OF salmon or COD | - | - | - | - | 1件: 97 97 💬
|
760 | Indigo | 1件: Indigo Indigo | - | - | - | 3件: 97 97, 289, 300 💬
|
761 | Indigo-carmine 0.2% using A spray catheter | 1件: Indigo Indigo | - | - | - | 1件: 97 97 💬
|
762 | Induction- PF-06480605 150 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
763 | Induction- PF-06480605 450 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
764 | Induction- PF-06480605 50 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
765 | Inflectra | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
766 | Inflectra 100 MG | - | - | - | - | 1件: 97 97 💬
|
767 | Inflectra 100 MG powder FOR concentrate FOR solution FOR infusion | - | - | - | - | 2件: 96 96, 97 💬
|
768 | Infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 24件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 164, 269, 270, 271 💬
|
769 | Infliximab 10 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
770 | Infliximab 5 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
771 | Infliximab adalimumab Y golimumab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
772 | Infliximab and adalimumab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
773 | Infliximab AT weeks 0 and 8 | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
774 | Infliximab AT weeks 0,2, and 6 | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
775 | Infliximab AT weeks 0,4, and 8 | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
776 | Infliximab infusion | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 💬
|
777 | Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
778 | Infliximab therapeutic drug monitoring | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
779 | Infliximab treatment | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
780 | Infliximab, adalimumab, certolizumab pegol | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
781 | Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
782 | Infliximab-biosimilar | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
783 | Infliximab-innovator | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
784 | Influenza vaccination | - | - | - | - | 2件: 97 97, 299 💬
|
785 | Influenza vaccine | - | - | - | - | 6件: 11 11, 13, 46, 51, 84, 97 💬
|
786 | Infusion OF saline | - | - | - | - | 1件: 97 97 💬
|
787 | Infusion rate OF infliximab | - | - | - | - | 1件: 97 97 💬
|
788 | Injectafer | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
789 | Injectafer 50 MG ijzer / ML oplossing voor injectie/infusie | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
790 | Innovator infliximab | - | - | - | - | 3件: 46 46, 96, 97 💬
|
791 | Inositol | 1件: Inositol Inositol | 1件: Inositol
Inositol
💬
| - | - | 2件: 96 96, 97 💬
|
792 | Intensify treatment with THE existing drug | - | - | - | - | 2件: 96 96, 97 💬
|
793 | Interferon BETA-1A | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
794 | Interferon-BETA-1A, 44 microgram | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 97 97 💬
|
795 | Interferon-BETA-1A, 66 microgram | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 97 97 💬
|
796 | Interleukin 2 | - | - | - | - | 11件: 35 35, 46, 49, 51, 56, 63, 95, 96, 97, 162, 271 💬
|
797 | Interleukin-11 | 1件: Oprelvekin Oprelvekin | 1件: Oprelvekin
Oprelvekin
💬
| 1件: IL11RA IL11RA 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 2件: 96 96, 97 💬
|
798 | Interleukin-2 | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 9件: 2 2, 13, 49, 50, 55, 65, 96, 97, 162 💬
|
799 | Intestinal flora capsule | - | - | - | - | 1件: 97 97 💬
|
800 | Intravenous (IV) infusions | - | - | - | - | 2件: 13 13, 97 💬
|
801 | Intravenous iron | - | - | - | - | 1件: 97 97 💬
|
802 | Intravenous iron sucrose | - | - | - | - | 1件: 97 97 💬
|
803 | Intravenous methylprednisolone | - | - | - | - | 3件: 13 13, 97, 145 💬
|
804 | Inulin sachet | 1件: Inulin Inulin | 1件: Inulin
Inulin
💬
| - | - | 1件: 97 97 💬
|
805 | INV-101 | - | - | - | - | 1件: 97 97 💬
|
806 | Iron | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 4件: 60 60, 96, 97, 238 💬
|
807 | Iron (III) hydroxide hydroxyethyl starch glucopheptonic acid complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
808 | Iron dextran | 2件: Iron Iron, Iron Dextran | 2件: Ferrous fumarate
Ferrous fumarate
,
Iron dextran
💬
| - | - | 2件: 62 62, 97 💬
|
809 | Iron HES complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
810 | Iron isomalto-oligosaccharide complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
811 | Iron isomaltoside | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
812 | Iron isomaltoside 1000 | 2件: Iron Iron, Iron isomaltoside 1000 | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
813 | Iron isomaltoside complex - iron isomaltoside 1000 | 2件: Iron Iron, Iron isomaltoside 1000 | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
814 | Iron oligosaccharide complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
815 | Iron status testing | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
816 | Iron sucrose | 2件: Iron Iron, Iron sucrose | 2件: Ferrous fumarate
Ferrous fumarate
,
Iron sucrose
💬
| - | - | 3件: 62 62, 96, 97 💬
|
817 | Iron sulfate | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
818 | Iron sulphate | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
819 | Iron sulphate 200MG coated tablets | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
820 | Iron supplement 300-600 MG/DAY | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
821 | Iron trivalent | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
822 | Iron(III) isomaltoside 1000 | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
823 | Iron(III)- hydroxide dextran complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
824 | Iron(III)-hydroxide dextran complex | - | - | - | - | 1件: 97 97 💬
|
825 | Itacitinib | 1件: Itacitinib Itacitinib | 2件: Itacitinib
Itacitinib
,
Itacitinib adipate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 51, 97, 228 💬
|
826 | Itacitinib adipate | 1件: Itacitinib Itacitinib | 2件: Itacitinib
Itacitinib
,
Itacitinib adipate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 97 97, 228 💬
|
827 | Itraconazole | 1件: Itraconazole Itraconazole | 1件: Itraconazole
Itraconazole
💬
| - | - | 7件: 2 2, 3, 65, 96, 97, 227, 299 💬
|
828 | IV corticosteroid | - | - | - | - | 1件: 97 97 💬
|
829 | IV tulisokibart | - | - | - | - | 2件: 96 96, 97 💬
|
830 | Izinova | - | - | - | - | 1件: 97 97 💬
|
831 | JAK inhibitor | - | - | - | - | 4件: 46 46, 50, 97, 325 💬
|
832 | Janus kinase inhibitor | - | - | - | - | 4件: 46 46, 97, 110, 162 💬
|
833 | JNJ-54781532 150 MG once daily | - | - | - | - | 1件: 97 97 💬
|
834 | JNJ-54781532 25 MG once daily | - | - | - | - | 1件: 97 97 💬
|
835 | JNJ-54781532 75 MG once daily | - | - | - | - | 1件: 97 97 💬
|
836 | JNJ-54781532 75 MG twice daily | - | - | - | - | 1件: 97 97 💬
|
837 | JNJ-54781532-AAD-10 MG | - | - | - | - | 1件: 97 97 💬
|
838 | JNJ-54781532-AAD-30 MG | - | - | - | - | 1件: 97 97 💬
|
839 | JNJ-54781532-AAD-5 MG | - | - | - | - | 1件: 97 97 💬
|
840 | JNJ-64841829 | - | - | - | - | 1件: 97 97 💬
|
841 | JNJ-64841842 | - | - | - | - | 1件: 97 97 💬
|
842 | JNJ-64841855 | - | - | - | - | 1件: 97 97 💬
|
843 | JNJ-64841894 | - | - | - | - | 1件: 97 97 💬
|
844 | JNJ-64841907 | - | - | - | - | 1件: 97 97 💬
|
845 | JNJ-64841920 | - | - | - | - | 1件: 97 97 💬
|
846 | JNJ-64841933 | - | - | - | - | 1件: 97 97 💬
|
847 | JNJ-64841946 | - | - | - | - | 1件: 97 97 💬
|
848 | JNJ-66525433 | - | - | - | - | 1件: 97 97 💬
|
849 | JNJ-72537634 | - | - | - | - | 1件: 97 97 💬
|
850 | JNJ-77242113 | - | - | - | - | 2件: 37 37, 97 💬
|
851 | JNJ-78934804 | - | - | - | - | 2件: 96 96, 97 💬
|
852 | Jyseleca | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬
|
853 | K(D)PT | - | - | - | - | 1件: 97 97 💬
|
854 | KamillenblüTEN 3ML/10ML | - | - | - | - | 1件: 97 97 💬
|
855 | Kappaproct | - | - | - | - | 1件: 97 97 💬
|
856 | KBL697 | - | - | - | - | 1件: 97 97 💬
|
857 | Kdpt | - | - | - | - | 1件: 97 97 💬
|
858 | KHK4083 | - | - | - | - | 1件: 97 97 💬
|
859 | Klean prep - polvere PER soluzione orale 4 bustine DA 69 G | - | - | - | - | 1件: 97 97 💬
|
860 | Klean-prep | 5件: Polyethylene glycol Polyethylene glycol, Potassium chloride, Sodium bicarbonate, Sodium chloride, Sodium sulfate | 8件: Sodium bicarbonate
Sodium bicarbonate
,
Anhydous sodium sulfate
,
Sodium chloride
,
Potassium chloride
,
Polyethylene glycol 3350
,
Sodium sulfate
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 1件: 97 97 💬
|
861 | Kleanlyte | - | - | - | - | 2件: 96 96, 97 💬
|
862 | Kremezin®, spherical adsorptive carbon | - | - | - | - | 2件: 96 96, 97 💬
|
863 | KRP203 | - | - | - | - | 1件: 97 97 💬
|
864 | KRP203A | - | - | - | - | 1件: 97 97 💬
|
865 | KSP-0243 | - | - | - | - | 1件: 97 97 💬
|
866 | KYO-dophilus | - | - | - | - | 1件: 97 97 💬
|
867 | Kümmel 2ML/10ML | - | - | - | - | 1件: 97 97 💬
|
868 | L-lysyl-D-prolyl-L-threonine acetate | 1件: Acetate Acetate | - | - | - | 1件: 97 97 💬
|
869 | L-lysyl-D-prolyl-lthreonine acetate, lyophilisate | - | - | - | - | 1件: 97 97 💬
|
870 | Laboratory biomarker analysis | - | - | - | - | 22件: 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
871 | Laboratory testing | - | - | - | - | 3件: 84 84, 97, 271 💬
|
872 | Lactated ringers | - | - | - | - | 2件: 96 96, 97 💬
|
873 | Lactobacillus casei | 1件: Lactobacillus casei Lactobacillus casei | 1件: Lactobacillus casei
Lactobacillus casei
💬
| - | - | 3件: 6 6, 97, 296 💬
|
874 | Lactobacillus casei DG | 1件: Lactobacillus casei Lactobacillus casei | 1件: Lactobacillus casei
Lactobacillus casei
💬
| - | - | 1件: 97 97 💬
|
875 | Lactobacillus GG | - | - | - | - | 1件: 97 97 💬
|
876 | Lactobacillus plantarum | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 2件: 6 6, 97 💬
|
877 | Lactobacillus reuteri | 1件: Lactobacillus reuteri Lactobacillus reuteri | - | - | - | 2件: 97 97, 299 💬
|
878 | Lactobacillus rhamnosus GG atcc 53103 | 1件: Lacticaseibacillus rhamnosus Lacticaseibacillus rhamnosus | - | - | - | 1件: 97 97 💬
|
879 | Lactobacillus salivarius UCC118 | 1件: Lactobacillus salivarius Lactobacillus salivarius | - | - | - | 2件: 96 96, 97 💬
|
880 | Lactobacilus acidophilus & bifidobacterium animalis/lactis | - | - | - | - | 1件: 97 97 💬
|
881 | Lactose IN water | 1件: Lactose Lactose | 2件: Anhydrous lactose
Anhydrous lactose
,
Lactose
💬
| - | - | 1件: 97 97 💬
|
882 | Lactose sachet | 1件: Lactose Lactose | 2件: Anhydrous lactose
Anhydrous lactose
,
Lactose
💬
| - | - | 1件: 97 97 💬
|
883 | Lactulose | 1件: Lactulose Lactulose | 1件: Lactulose
Lactulose
💬
| - | - | 3件: 6 6, 13, 97 💬
|
884 | LAP TAP bupivacaine/epinephrine | - | - | - | - | 2件: 96 96, 97 💬
|
885 | LC51-0255 | - | - | - | - | 1件: 97 97 💬
|
886 | LDP-02 | - | - | - | - | 2件: 96 96, 97 💬
|
887 | Lenograstim | 1件: Lenograstim Lenograstim | 1件: Lenograstim
Lenograstim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 8件: 2 2, 13, 16, 18, 19, 57, 65, 97 💬
|
888 | Levocarnitine | 1件: Levocarnitine Levocarnitine | 2件: Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | 3件: 3 3, 53, 97 💬
|
889 | Levocarnitine propyl hydrochloride | 1件: Levocarnitine Levocarnitine | 2件: Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | 1件: 97 97 💬
|
890 | Levotonine | - | - | - | - | 1件: 97 97 💬
|
891 | Levovanox | - | - | - | - | 2件: 94 94, 97 💬
|
892 | Linaclotide | 1件: Linaclotide Linaclotide | 2件: Linaclotide acetate
Linaclotide acetate
,
Linaclotide
💬
| 1件: GUCY2C GUCY2C 💬
| 2件: Hormone signaling Hormone signaling, Purine metabolism 💬 | 2件: 6 6, 97 💬
|
893 | Liposomal curcumin | - | - | - | - | 1件: 97 97 💬
|
894 | LIV001 | - | - | - | - | 1件: 97 97 💬
|
895 | Live SK08 powder | - | - | - | - | 1件: 97 97 💬
|
896 | Lixacol | - | - | - | - | 1件: 97 97 💬
|
897 | LMT503 | - | - | - | - | 2件: 96 96, 97 💬
|
898 | Loperamide | 1件: Loperamide Loperamide | 2件: Loperamide hydrochloride
Loperamide hydrochloride
,
Loperamide
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 97 💬
|
899 | Loperamide hydrochloride | 1件: Loperamide Loperamide | 2件: Loperamide hydrochloride
Loperamide hydrochloride
,
Loperamide
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 97 97 💬
|
900 | Losartan | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 15件: 17 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
|
901 | Lovoldyl*30CPR RIV 5MG | - | - | - | - | 1件: 97 97 💬
|
902 | LOW dose | - | - | - | - | 1件: 97 97 💬
|
903 | LOW dose budesonide | - | - | - | - | 1件: 97 97 💬
|
904 | LOW dose budesonide rectal foam | - | - | - | - | 1件: 97 97 💬
|
905 | LOW dose MT-1303 | - | - | - | - | 1件: 97 97 💬
|
906 | LOW dose naltrexone | - | - | - | - | 2件: 96 96, 97 💬
|
907 | LOW fodmap | - | - | - | - | 1件: 97 97 💬
|
908 | LOW fodmap diet | - | - | - | - | 1件: 97 97 💬
|
909 | LOW protein and high fiber diet | - | - | - | - | 1件: 97 97 💬
|
910 | LOW-dose CICR-NAM | - | - | - | - | 1件: 97 97 💬
|
911 | LT-02 | - | - | - | - | 1件: 97 97 💬
|
912 | Lubiprostone | 1件: Lubiprostone Lubiprostone | 1件: Lubiprostone
Lubiprostone
💬
| 1件: CLCN2 CLCN2 💬
| 1件: Mineral absorption Mineral absorption 💬 | 5件: 6 6, 13, 97, 290, 299 💬
|
913 | Lumbar puncture | - | - | - | - | 6件: 6 6, 13, 19, 96, 97, 127 💬
|
914 | Lusvertikimab | 1件: Lusvertikimab Lusvertikimab | 1件: Lusvertikimab
Lusvertikimab
💬
| 1件: IL7R IL7R 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, FoxO signaling pathway, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency 💬 | 1件: 97 97 💬
|
915 | Lutikizumab | 1件: Lutikizumab Lutikizumab | 1件: Lutikizumab
Lutikizumab
💬
| 2件: IL1A IL1A, IL1B 💬
| 44件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 3件: 46 46, 96, 97 💬
|
916 | LX1606 | - | - | - | - | 1件: 97 97 💬
|
917 | LY3074828 | - | - | - | - | 2件: 96 96, 97 💬
|
918 | LY3471851 | - | - | - | - | 2件: 49 49, 97 💬
|
919 | LYC-30937 | - | - | - | - | 1件: 97 97 💬
|
920 | LYC-30937-EC | - | - | - | - | 1件: 97 97 💬
|
921 | LYS006 | - | - | - | - | 1件: 97 97 💬
|
922 | Lysine-D-proline-threonine | 1件: Lysine Lysine | 4件: Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | 1件: 97 97 💬
|
923 | Macrogol | 1件: Polyethylene glycol Polyethylene glycol | 3件: Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 2件: 97 97, 299 💬
|
924 | Macrogol 3350 | 1件: Polyethylene glycol Polyethylene glycol | 3件: Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 1件: 97 97 💬
|
925 | Magnesio solfato eptaidrato | 1件: Magnesium Magnesium | - | - | - | 1件: 97 97 💬
|
926 | Magnesium citrate | 2件: Magnesium Magnesium, Magnesium citrate | 1件: Magnesium citrate
Magnesium citrate
💬
| - | - | 1件: 97 97 💬
|
927 | Magnesium sulfate heptahydrate | 2件: Magnesium Magnesium, Magnesium sulfate | 1件: Magnesium sulfate
Magnesium sulfate
💬
| - | - | 1件: 97 97 💬
|
928 | Magnesium sulphate heptahydrate | 2件: Magnesium Magnesium, Magnesium sulfate | 1件: Magnesium sulfate
Magnesium sulfate
💬
| - | - | 1件: 97 97 💬
|
929 | Magnesium sulphate heptaydrate | 2件: Magnesium Magnesium, Magnesium sulfate | 1件: Magnesium sulfate
Magnesium sulfate
💬
| - | - | 1件: 97 97 💬
|
930 | Magnetic resonance imaging scanning | - | - | - | - | 1件: 97 97 💬
|
931 | Maltodextrin | 1件: Maltodextrin Maltodextrin | 1件: Maltodextrin
Maltodextrin
💬
| - | - | 4件: 6 6, 13, 96, 97 💬
|
932 | Maltose | 1件: Maltose Maltose | 1件: Maltose
Maltose
💬
| - | - | 1件: 97 97 💬
|
933 | Mango polyphenolics | 1件: Mango Mango | - | - | - | 2件: 96 96, 97 💬
|
934 | Mare´S milk | - | - | - | - | 2件: 96 96, 97 💬
|
935 | Matricaria flower | 1件: Chamomile Chamomile | 1件: German chamomile flower
German chamomile flower
💬
| - | - | 1件: 97 97 💬
|
936 | Matricaria recutita L. flos | - | - | - | - | 1件: 97 97 💬
|
937 | Maximal oral 5ASA | - | - | - | - | 1件: 97 97 💬
|
938 | MB-001 | - | - | - | - | 1件: 97 97 💬
|
939 | MB310 | - | - | - | - | 1件: 97 97 💬
|
940 | MDX-1100 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
941 | Mebendazole | 1件: Mebendazole Mebendazole | 1件: Mebendazole
Mebendazole
💬
| - | - | 1件: 97 97 💬
|
942 | MEDI2070 | - | - | - | - | 2件: 96 96, 97 💬
|
943 | MEDI7183 high dose | - | - | - | - | 1件: 97 97 💬
|
944 | MEDI7183 LOW dose | - | - | - | - | 1件: 97 97 💬
|
945 | MEDI7183 medium dose | - | - | - | - | 1件: 97 97 💬
|
946 | Medical cannabis | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 3件: 6 6, 96, 97 💬
|
947 | Mediterranean diet | - | - | - | - | 6件: 13 13, 77, 96, 97, 265, 299 💬
|
948 | Medium chain triglycerides | - | - | - | - | 2件: 96 96, 97 💬
|
949 | Melatonin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 16件: 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
|
950 | Melissae folii DRY aqueous extract | - | - | - | - | 1件: 97 97 💬
|
951 | Melissenblätter 15ML/10ML | - | - | - | - | 1件: 97 97 💬
|
952 | Melitracen | 1件: Melitracen Melitracen | 1件: Melitracen
Melitracen
💬
| - | - | 1件: 97 97 💬
|
953 | Menatetrenone | 1件: Menatetrenone Menatetrenone | 1件: Menatetrenone
Menatetrenone
💬
| - | - | 2件: 66 66, 97 💬
|
954 | Mentha × piperita L. folium | - | - | - | - | 1件: 97 97 💬
|
955 | Mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: hprT hprT 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
956 | Mesalamin | - | - | - | - | 1件: 97 97 💬
|
957 | Mesalamine | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 3件: 96 96, 97, 164 💬
|
958 | Mesalamine and alpha-lipoic acid | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
959 | Mesalamine delayed release tablets 400MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
960 | Mesalamine enema | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
961 | Mesalamine granules | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
962 | Mesalamine ONCE-daily | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
963 | Mesalamine twice-daily | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
964 | Mesalamine, 5-ASA | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
965 | Mesalazina | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
966 | Mesalazine | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 3件: 46 46, 96, 97 💬
|
967 | Mesalazine - TID 1000 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
968 | Mesalazine - TID 2X 500 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
969 | Mesalazine 1000 MG gastro-resistant tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
970 | Mesalazine 250MG tablet and nitazoxanide 500MG oral tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
971 | Mesalazine 4G enema | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
972 | Mesalazine 500 MG gastro-resistant tablets (salofa | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
973 | Mesalazine enema | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
974 | Mesalazine liquid enema | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
975 | Mesalazine SLOW-release granules | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
976 | Mesalazine suppository treatment | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
977 | Mesalazine with hydrocortisone sodium succinate | 2件: Hydrocortisone Hydrocortisone, Mesalazine | 2件: Hydrocortisone
Hydrocortisone
,
Mesalamine
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
978 | Mesalazinum | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
979 | Mesenchymal cells | - | - | - | - | 1件: 97 97 💬
|
980 | Mesenchymal stem cells | - | - | - | - | 17件: 2 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 97, 107, 222, 271, 274, 298, 299 💬
|
981 | Mesenchymal stromal cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 8件: 36 36, 51, 60, 96, 97, 107, 274, 284 💬
|
982 | MET-2 | - | - | - | - | 1件: 97 97 💬
|
983 | Metformin | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 23件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
|
984 | Metformin 500 MG TID oral tablet | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
985 | Methalazine suppository WAS given rectally once A DAY | - | - | - | - | 1件: 97 97 💬
|
986 | Methane | 1件: Methane Methane | - | - | - | 1件: 97 97 💬
|
987 | Methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 37件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
988 | Methotrexate bellon 25MG/ML | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 97 97 💬
|
989 | Methotrexate disodium | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 5件: 46 46, 96, 97, 107, 271 💬
|
990 | Methotrexate injection | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 2件: 96 96, 97 💬
|
991 | Methylene blue 25MG tablets | 1件: Methylene blue Methylene blue | 2件: Methylene blue
Methylene blue
,
Methylthioninium chloride hydrate
💬
| - | - | 1件: 97 97 💬
|
992 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
993 | Methylprednisolone sodium hemisuccinate | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 13 13, 85, 97 💬
|
994 | Metoject | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 6件: 41 41, 46, 96, 97, 107, 271 💬
|
995 | Metotrexat | - | - | - | - | 3件: 50 50, 96, 97 💬
|
996 | Metronidazole | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 💬
|
997 | Metronidazole capsule 50 MG | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 1件: 97 97 💬
|
998 | Mezavant | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
999 | Mezavant 1200 MG magensaftresistente retardtabletten | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1000 | Mezavant gastro-resistant, prolonged release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1001 | Mezavant XL 1200 MG gastro-resistant prolonged release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1002 | Mezavant XL 1200 MG gastro-resistant, prolonged release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1003 | Mezavant XL 1200MG gastro-resistant, prolonged release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1004 | Mezavant XL gastro-resistant, prolonged release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1005 | MH002 | - | - | - | - | 1件: 97 97 💬
|
1006 | Microbiome | - | - | - | - | 1件: 97 97 💬
|
1007 | Microbiota capsule | - | - | - | - | 1件: 97 97 💬
|
1008 | Microbiota suspension | - | - | - | - | 1件: 97 97 💬
|
1009 | Microbiote FéCAL | - | - | - | - | 1件: 97 97 💬
|
1010 | Microcrystalline cellulose | 1件: Microcrystalline cellulose Microcrystalline cellulose | 2件: Microcrystalline cellulose
Microcrystalline cellulose
,
Rayon, purified
💬
| - | - | 1件: 97 97 💬
|
1011 | Midazolam | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 46, 67, 96, 97, 231, 272, 298, 299 💬
|
1012 | Midazolam 2 MG | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 96 96, 97 💬
|
1013 | Midazolam B. braun | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 97 97 💬
|
1014 | Midazolam B.braun | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 97 97 💬
|
1015 | Milk | - | - | - | - | 2件: 96 96, 97 💬
|
1016 | Minocycline | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 14件: 2 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
|
1017 | Mirikizumab | 1件: Mirikizumab Mirikizumab | 1件: Mirikizumab
Mirikizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 37 37, 96, 97 💬
|
1018 | Mirikizumab IV | 1件: Mirikizumab Mirikizumab | 1件: Mirikizumab
Mirikizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 97 97 💬
|
1019 | Mirikizumab SC | 1件: Mirikizumab Mirikizumab | 1件: Mirikizumab
Mirikizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 97 97 💬
|
1020 | Mirtazapine | 1件: Mirtazapine Mirtazapine | 1件: Mirtazapine
Mirtazapine
💬
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, HTR2, HTR2, HTR2, HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 2件: 85 85, 97 💬
|
1021 | Mitoq | - | - | - | - | 3件: 2 2, 6, 97 💬
|
1022 | MK-6194 | - | - | - | - | 2件: 49 49, 97 💬
|
1023 | MK-8259 | - | - | - | - | 1件: 97 97 💬
|
1024 | MLN0002 | - | - | - | - | 3件: 94 94, 96, 97 💬
|
1025 | MLN0002 SC | - | - | - | - | 2件: 96 96, 97 💬
|
1026 | MLN002 | - | - | - | - | 2件: 96 96, 97 💬
|
1027 | MMX mesalamine | - | - | - | - | 1件: 97 97 💬
|
1028 | MMX mesalamine/ mesalazine | - | - | - | - | 1件: 97 97 💬
|
1029 | MMX mesalamine/mesalazine | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1030 | Modified gegen qinlian decoction | - | - | - | - | 1件: 97 97 💬
|
1031 | Modified-release phosphatidylcholine | - | - | - | - | 1件: 97 97 💬
|
1032 | Mongersen | 1件: Mongersen Mongersen | 1件: Mongersen
Mongersen
💬
| 1件: SMAD7 SMAD7 💬
| 2件: Hippo signaling pathway Hippo signaling pathway, TGF-beta signaling pathway 💬 | 2件: 96 96, 97 💬
|
1033 | Monoclonal antibody ANTI-IGG1 | - | - | - | - | 3件: 37 37, 96, 97 💬
|
1034 | Monofer | 1件: Iron isomaltoside 1000 Iron isomaltoside 1000 | - | - | - | 1件: 97 97 💬
|
1035 | Monofer 100 MG/ML | 1件: Iron isomaltoside 1000 Iron isomaltoside 1000 | - | - | - | 1件: 97 97 💬
|
1036 | Monofer 100MG/ML | 1件: Iron isomaltoside 1000 Iron isomaltoside 1000 | - | - | - | 1件: 97 97 💬
|
1037 | Montmorency tart cherry | - | - | - | - | 1件: 97 97 💬
|
1038 | MORF-057 | - | - | - | - | 2件: 96 96, 97 💬
|
1039 | Morning group | - | - | - | - | 1件: 97 97 💬
|
1040 | Moviprep polvo para solucióN oral | - | - | - | - | 2件: 96 96, 97 💬
|
1041 | Moviprep sabor naranja | 6件: Ascorbic acid Ascorbic acid, Polyethylene glycol, Potassium chloride, Sodium ascorbate, Sodium chloride, Sodium sulfate | 9件: Ascorbic acid
Ascorbic acid
,
Anhydous sodium sulfate
,
Sodium chloride
,
Potassium chloride
,
Polyethylene glycol 3350
,
Sodium ascorbate
,
Sodium sulfate
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 1件: 97 97 💬
|
1042 | Mrna COVD19 vaccine | - | - | - | - | 4件: 49 49, 53, 97, 271 💬
|
1043 | MS-20 oral solution | - | - | - | - | 1件: 97 97 💬
|
1044 | MSC | - | - | - | - | 5件: 51 51, 60, 96, 97, 271 💬
|
1045 | MT-1303 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
1046 | MTX 12.5 | - | - | - | - | 1件: 97 97 💬
|
1047 | MTX 25 | - | - | - | - | 1件: 97 97 💬
|
1048 | Multi-strain probiotics | - | - | - | - | 1件: 97 97 💬
|
1049 | Multiple DOSE- group B | - | - | - | - | 1件: 97 97 💬
|
1050 | Multiple DOSE-group B | - | - | - | - | 1件: 97 97 💬
|
1051 | Multistem | 1件: MultiStem MultiStem | - | - | - | 1件: 97 97 💬
|
1052 | Multistem high dose | 1件: MultiStem MultiStem | - | - | - | 1件: 97 97 💬
|
1053 | Multistem LOW dose | 1件: MultiStem MultiStem | - | - | - | 1件: 97 97 💬
|
1054 | Mycodigest supplement | - | - | - | - | 2件: 96 96, 97 💬
|
1055 | Myrrh | 1件: Myrrh Myrrh | 1件: Myrrh
Myrrh
💬
| - | - | 1件: 97 97 💬
|
1056 | Nabilone | 1件: Nabilone Nabilone | 1件: Nabilone
Nabilone
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 4件: 6 6, 13, 97, 127 💬
|
1057 | Naltrexone hydrochloride | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
1058 | Nanocort | - | - | - | - | 3件: 13 13, 46, 97 💬
|
1059 | Neomycin | 1件: Neomycin Neomycin | 3件: Neomycin sulfate
Neomycin sulfate
,
Neomycin palmitate
,
Neomycin
💬
| - | - | 3件: 96 96, 97, 296 💬
|
1060 | Neoral | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 60 60, 97, 222 💬
|
1061 | Neoral soft gelatin capsules | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 97 97, 269 💬
|
1062 | Nestle impact immunonutrition | - | - | - | - | 1件: 97 97 💬
|
1063 | Niclosamide | 1件: Niclosamide Niclosamide | 1件: Niclosamide
Niclosamide
💬
| - | - | 2件: 46 46, 97 💬
|
1064 | Nicolon | - | - | - | - | 1件: 97 97 💬
|
1065 | Nicotinamide mononucleotide | 2件: Nicotinamide Nicotinamide, Nicotinamide Mononucleotide | 1件: Niacinamide
Niacinamide
💬
| - | - | 1件: 97 97 💬
|
1066 | Nicotinamide riboside chloride | 2件: Nicotinamide Nicotinamide, Nicotinamide riboside | 1件: Niacinamide
Niacinamide
💬
| - | - | 1件: 97 97 💬
|
1067 | Nifuroxazide | 1件: Nifuroxazide Nifuroxazide | 1件: Nifuroxazide
Nifuroxazide
💬
| - | - | 1件: 97 97 💬
|
1068 | Nitric oxide | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 8件: 51 51, 85, 86, 88, 97, 210, 294, 299 💬
|
1069 | Nivolumab | 1件: Nivolumab Nivolumab | 1件: Nivolumab
Nivolumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
1070 | Nolpitantium besylate | - | - | - | - | 1件: 97 97 💬
|
1071 | NON AS OF YET | - | - | - | - | 1件: 97 97 💬
|
1072 | NON-exposed group | - | - | - | - | 1件: 97 97 💬
|
1073 | NON-genotyping | - | - | - | - | 1件: 97 97 💬
|
1074 | None given | - | - | - | - | 1件: 97 97 💬
|
1075 | Norditropin simplexx | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 3件: 97 97, 193, 195 💬
|
1076 | Norditropin® simplexx® 5MG/1.5ML | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 97 97 💬
|
1077 | Normal diet | - | - | - | - | 2件: 96 96, 97 💬
|
1078 | Normal dietetic scheme | - | - | - | - | 1件: 97 97 💬
|
1079 | Normal saline | - | - | - | - | 20件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
|
1080 | Normal saline enema | - | - | - | - | 1件: 97 97 💬
|
1081 | NOT YET assigned | - | - | - | - | 2件: 36 36, 97 💬
|
1082 | Nutrition specialist | - | - | - | - | 1件: 97 97 💬
|
1083 | Nutrition supplement | - | - | - | - | 1件: 97 97 💬
|
1084 | Nutritional dietary intervention | - | - | - | - | 2件: 96 96, 97 💬
|
1085 | NX-13 250 MG | - | - | - | - | 1件: 97 97 💬
|
1086 | NX-13 250MG | - | - | - | - | 1件: 97 97 💬
|
1087 | NX-13 250MG IR | - | - | - | - | 1件: 97 97 💬
|
1088 | NX-13 500MG IR | - | - | - | - | 1件: 97 97 💬
|
1089 | NX-13 500MG MR | - | - | - | - | 1件: 97 97 💬
|
1090 | NX-13 750MG | - | - | - | - | 1件: 97 97 💬
|
1091 | Obefazimod | - | - | - | - | 2件: 96 96, 97 💬
|
1092 | OD-07656 | - | - | - | - | 3件: 96 96, 97, 110 💬
|
1093 | Oligofructose-enriched inulin OI | - | - | - | - | 1件: 97 97 💬
|
1094 | Olimel parenteral nutrition | - | - | - | - | 1件: 97 97 💬
|
1095 | Omeprazole | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 12件: 6 6, 13, 21, 46, 85, 90, 96, 97, 98, 271, 282, 298 💬
|
1096 | Omeprazole 20 MG | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 2件: 96 96, 97 💬
|
1097 | Ondansetron hydrochloride dihydrate | 1件: Ondansetron Ondansetron | 2件: Ondansetron
Ondansetron
,
Ondansetron hydrochloride hydrate
💬
| 5件: HTR3 HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 6 6, 97 💬
|
1098 | Ontamalimab | 1件: Ontamalimab Ontamalimab | - | - | - | 2件: 96 96, 97 💬
|
1099 | OPC-6535 | - | - | - | - | 2件: 96 96, 97 💬
|
1100 | OPEN-label | - | - | - | - | 1件: 97 97 💬
|
1101 | OPRX-106 | - | - | - | - | 1件: 97 97 💬
|
1102 | OPRX-106 (plant cells expressing TNFR-FC) 2MG | - | - | - | - | 1件: 97 97 💬
|
1103 | OPRX-106 (plant cells expressing TNFR-FC) 8MG | - | - | - | - | 1件: 97 97 💬
|
1104 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO methylprednisolone | - | - | - | - | 1件: 97 97 💬
|
1105 | Oral budesonide | - | - | - | - | 2件: 97 97, 98 💬
|
1106 | Oral cholera vaccine | - | - | - | - | 1件: 97 97 💬
|
1107 | Oral corticosteroids | - | - | - | - | 4件: 13 13, 46, 97, 251 💬
|
1108 | Oral ferrous sulfate | - | - | - | - | 1件: 97 97 💬
|
1109 | Oral iron | - | - | - | - | 2件: 97 97, 254 💬
|
1110 | Oral liposomal iron | - | - | - | - | 1件: 97 97 💬
|
1111 | Oral OKT3 | - | - | - | - | 1件: 97 97 💬
|
1112 | Oral vancomycin | - | - | - | - | 3件: 94 94, 97, 296 💬
|
1113 | Ordinary meat diet | - | - | - | - | 1件: 97 97 💬
|
1114 | ORE1001 | - | - | - | - | 1件: 97 97 💬
|
1115 | Orencia | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 15件: 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271, 300 💬
|
1116 | Originator (legacy) drug | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
1117 | OSE-127 | - | - | - | - | 2件: 53 53, 97 💬
|
1118 | Oseltamivir | 1件: Oseltamivir Oseltamivir | 2件: Oseltamivir phosphate
Oseltamivir phosphate
,
Oseltamivir
💬
| - | - | 2件: 97 97, 299 💬
|
1119 | OST-122 | - | - | - | - | 1件: 97 97 💬
|
1120 | Other biologic agents | - | - | - | - | 2件: 96 96, 97 💬
|
1121 | Other biologic therapies | - | - | - | - | 2件: 96 96, 97 💬
|
1122 | Overencapsulated azathioprine (imuran) 50 MG tablet | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
1123 | Overencapsulated mesalazine tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1124 | Oxitriptan | 1件: Oxitriptan Oxitriptan | 1件: Oxitriptan
Oxitriptan
💬
| - | - | 1件: 97 97 💬
|
1125 | Oxygen GAS FOR inhalation | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 2件: 96 96, 97 💬
|
1126 | Oxygen medicinal GAS SOL 100% V/V medicinal GAS, compressed | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 1件: 97 97 💬
|
1127 | Ozanimod | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
1128 | Ozanimod HCL | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
1129 | Ozanimod hydrochloride | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
1130 | Ozanimod oral capsule | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 97 💬
|
1131 | Pain questionnaires | - | - | - | - | 1件: 97 97 💬
|
1132 | PALI-2108 | - | - | - | - | 1件: 97 97 💬
|
1133 | Palmitoleic acid | 1件: Palmitoleic Acid Palmitoleic Acid | - | - | - | 1件: 97 97 💬
|
1134 | Pancrelipase | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | 4件: 96 96, 97, 298, 299 💬
|
1135 | Parnaparin sodium | 1件: Parnaparin Parnaparin | - | - | - | 1件: 97 97 💬
|
1136 | Partial enteral nutrition | - | - | - | - | 3件: 96 96, 97, 271 💬
|
1137 | PBF-677 | - | - | - | - | 1件: 97 97 💬
|
1138 | PCR-rflp | - | - | - | - | 1件: 97 97 💬
|
1139 | PEG | - | - | - | - | 8件: 6 6, 13, 41, 46, 76, 97, 246, 337 💬
|
1140 | PEG LOW volume with bisacodyl | - | - | - | - | 1件: 97 97 💬
|
1141 | PEG-liposomal prednisolone sodium phosphate | 2件: Phosphate ion Phosphate ion, Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 97 💬
|
1142 | Pending | - | - | - | - | 7件: 6 6, 13, 19, 96, 97, 113, 302 💬
|
1143 | Pentasa | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
1144 | Pentasa 500 MG retardtabletten | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1145 | Pentasa compact 2G, granulate with prolonged release | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1146 | Pentasa compact 4G, granulate with prolonged release | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1147 | Pentasa enema | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1148 | Pentasa prolonged release granules 2G | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1149 | Pentasa sachet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
1150 | Pentasa sachet 1 G | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1151 | Pentasa sachet 1G | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1152 | Pentasa sachet 2 G | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1153 | Pentoxifylline | 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline
Pentoxifylline
💬
| - | - | 11件: 26 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
|
1154 | Pentoxifylline 400 MG | 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline
Pentoxifylline
💬
| - | - | 2件: 6 6, 97 💬
|
1155 | Period 1 IBI112 dose 1 | - | - | - | - | 1件: 97 97 💬
|
1156 | Period 1 IBI112 dose 2 | - | - | - | - | 1件: 97 97 💬
|
1157 | Period 2 IBI112 dose 3 | - | - | - | - | 1件: 97 97 💬
|
1158 | Period 2 IBI112 dose 4 | - | - | - | - | 1件: 97 97 💬
|
1159 | Personalized B-fructan diet | - | - | - | - | 1件: 97 97 💬
|
1160 | Personalized pectin diet | - | - | - | - | 1件: 97 97 💬
|
1161 | Pethidine | 1件: Meperidine Meperidine | 2件: Meperidine hydrochloride
Meperidine hydrochloride
,
Pethidine
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 97 97, 298 💬
|
1162 | PF 06687234 | - | - | - | - | 2件: 96 96, 97 💬
|
1163 | PF-00547659 | - | - | - | - | 2件: 96 96, 97 💬
|
1164 | PF-00547659 SC injection | - | - | - | - | 2件: 96 96, 97 💬
|
1165 | PF-05230917 | - | - | - | - | 1件: 97 97 💬
|
1166 | PF-05285401 | - | - | - | - | 1件: 97 97 💬
|
1167 | PF-06480605 | - | - | - | - | 1件: 97 97 💬
|
1168 | PF-06480605 100 MG/ML | - | - | - | - | 1件: 97 97 💬
|
1169 | PF-06651600 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
1170 | PF-06651600 10 MG | - | - | - | - | 1件: 97 97 💬
|
1171 | PF-06651600 50 MG | - | - | - | - | 2件: 96 96, 97 💬
|
1172 | PF-06651600-15 | - | - | - | - | 2件: 96 96, 97 💬
|
1173 | PF-06687234 | - | - | - | - | 1件: 97 97 💬
|
1174 | PF-06700841 25 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 2件: 96 96, 97 💬
|
1175 | PF-06700841 5 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 2件: 96 96, 97 💬
|
1176 | PF-06700841-15 | 1件: PF-06700841 PF-06700841 | - | - | - | 3件: 49 49, 96, 97 💬
|
1177 | PF-06826647 | - | - | - | - | 1件: 97 97 💬
|
1178 | PF-06826647 100 MG QD | - | - | - | - | 1件: 97 97 💬
|
1179 | PF-06826647 300 MG QD | - | - | - | - | 1件: 97 97 💬
|
1180 | PF-06826647 600 MG QD | - | - | - | - | 1件: 97 97 💬
|
1181 | PF-07054894 | - | - | - | - | 1件: 97 97 💬
|
1182 | PF-6826647 400 MG QD | - | - | - | - | 1件: 97 97 💬
|
1183 | Pfefferminzblätter 1ML/10ML | - | - | - | - | 1件: 97 97 💬
|
1184 | Pfizer comirnaty vaccine | - | - | - | - | 1件: 97 97 💬
|
1185 | PGX-guided POST-operative pain management | - | - | - | - | 2件: 96 96, 97 💬
|
1186 | Phentermine-topiramate | 1件: Phentermine Phentermine | 2件: Phentermine
Phentermine
,
Phentermine hydrochloride
💬
| 5件: MAO MAO, MAO, SLC6A2, SLC6A3, SLC6A4 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 97 97 💬
|
1187 | Physician-prescribed exercise programme | - | - | - | - | 1件: 97 97 💬
|
1188 | Picosulfate | 1件: Picosulfuric acid Picosulfuric acid | - | - | - | 1件: 97 97 💬
|
1189 | PK-model TO decide when TO dose vedolizumab and ustekinumab | - | - | - | - | 2件: 96 96, 97 💬
|
1190 | PL8177 | - | - | - | - | 1件: 97 97 💬
|
1191 | PN-10884A | - | - | - | - | 1件: 97 97 💬
|
1192 | PN-943 | - | - | - | - | 1件: 97 97 💬
|
1193 | Pneumo 23 | - | - | - | - | 2件: 65 65, 97 💬
|
1194 | Pneumococcal pneumonia vaccine | - | - | - | - | 1件: 97 97 💬
|
1195 | Pneumovax | - | - | - | - | 4件: 46 46, 49, 96, 97 💬
|
1196 | Polaprezinc | 1件: Polaprezinc Polaprezinc | 1件: Polaprezinc
Polaprezinc
💬
| - | - | 2件: 96 96, 97 💬
|
1197 | Polietilenglicole | - | - | - | - | 1件: 97 97 💬
|
1198 | Polyethylene glycol | 1件: Polyethylene glycol Polyethylene glycol | 3件: Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 4件: 50 50, 97, 195, 299 💬
|
1199 | Polyethylene glycols | - | - | - | - | 1件: 97 97 💬
|
1200 | Polyphenon E | 1件: Sinecatechins Sinecatechins | 1件: Sinecatechins
Sinecatechins
💬
| - | - | 3件: 13 13, 36, 97 💬
|
1201 | Potassio solfato | - | - | - | - | 1件: 97 97 💬
|
1202 | Potassium chloride | 2件: Potassium Potassium, Potassium chloride | 2件: Potassium chloride
Potassium chloride
,
Potassium
💬
| - | - | 1件: 97 97 💬
|
1203 | Potassium sulphate | 2件: Potassium Potassium, Potassium sulfate | 2件: Potassium sulfate
Potassium sulfate
,
Potassium
💬
| - | - | 1件: 97 97 💬
|
1204 | PRA023 | - | - | - | - | 3件: 51 51, 96, 97 💬
|
1205 | PRD5973697 | - | - | - | - | 1件: 97 97 💬
|
1206 | PRE-filled syringe | - | - | - | - | 7件: 46 46, 49, 53, 96, 97, 107, 271 💬
|
1207 | PRE-genotype NUDT15 and optimize azathioprine dosage | - | - | - | - | 1件: 97 97 💬
|
1208 | Prebiotic | - | - | - | - | 2件: 96 96, 97 💬
|
1209 | Prebiotics | - | - | - | - | 2件: 96 96, 97 💬
|
1210 | Precision dosing infliximab | - | - | - | - | 1件: 97 97 💬
|
1211 | Prednisolon | - | - | - | - | 7件: 46 46, 51, 66, 95, 96, 97, 251 💬
|
1212 | Prednisolon jenapharm | - | - | - | - | 2件: 96 96, 97 💬
|
1213 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
1214 | Prednisolone sodium metasulphobenzoate | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
1215 | Prednisolone tablets B.P. 5MG | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
1216 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
1217 | Prednisone oral product | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
1218 | Prefilled syringe delivery OF golimumab | - | - | - | - | 1件: 97 97 💬
|
1219 | Pretreatment antibiotics | - | - | - | - | 1件: 97 97 💬
|
1220 | Prevenar 13 | - | - | - | - | 4件: 13 13, 46, 96, 97 💬
|
1221 | Previously referred TO AS MEDI2070 and AMG 139 | - | - | - | - | 1件: 97 97 💬
|
1222 | PRIM-DJ2727 | - | - | - | - | 3件: 6 6, 51, 97 💬
|
1223 | PRIM-DJ2727 - capsules | - | - | - | - | 1件: 97 97 💬
|
1224 | PRIM-DJ2727 - frozen | - | - | - | - | 1件: 97 97 💬
|
1225 | PRO145223 | - | - | - | - | 1件: 97 97 💬
|
1226 | Probiotic | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 9件: 2 2, 6, 93, 96, 97, 127, 193, 266, 299 💬
|
1227 | Probiotic - VSL#3 | - | - | - | - | 2件: 96 96, 97 💬
|
1228 | Probiotic formula capsule | - | - | - | - | 1件: 97 97 💬
|
1229 | Probiotic mixture | - | - | - | - | 2件: 96 96, 97 💬
|
1230 | Probiotics | - | - | - | - | 6件: 6 6, 94, 96, 97, 206, 291 💬
|
1231 | Products containing aminosalicylate | - | - | - | - | 1件: 97 97 💬
|
1232 | Products containing azathioprine or 6-mercaptopurine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
1233 | Prolife | - | - | - | - | 1件: 97 97 💬
|
1234 | Promiten | - | - | - | - | 1件: 97 97 💬
|
1235 | Propionate | 1件: Propionate ion Propionate ion | - | - | - | 1件: 97 97 💬
|
1236 | Propionyl L-carnitine | 1件: Levocarnitine Levocarnitine | 2件: Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | 1件: 97 97 💬
|
1237 | Propionyl L-carnitine hydrochloride | 1件: Levocarnitine Levocarnitine | 2件: Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | 1件: 97 97 💬
|
1238 | Propionyl-L-carnitine | 2件: Levocarnitine Levocarnitine, Levocarnitine propionate | 3件: Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
,
Levocarnitine propionate hydrochloride
💬
| - | - | 1件: 97 97 💬
|
1239 | Propionylcarnitinhydrochlorid | - | - | - | - | 1件: 97 97 💬
|
1240 | Propofol | 1件: Propofol Propofol | 1件: Propofol
Propofol
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 10件: 3 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
|
1241 | Propofol B. braun | 1件: Propofol Propofol | 1件: Propofol
Propofol
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 97 97 💬
|
1242 | Protein hydrolysate | 1件: Protein hydrolysate Protein hydrolysate | 1件: Protein hydrolysate
Protein hydrolysate
💬
| - | - | 1件: 97 97 💬
|
1243 | PRV-300 | - | - | - | - | 1件: 97 97 💬
|
1244 | Psyllium husk powder | 1件: Plantago seed Plantago seed | 2件: Plantago seed
Plantago seed
,
Psyllium husk
💬
| - | - | 1件: 97 97 💬
|
1245 | PTG-100 | - | - | - | - | 1件: 97 97 💬
|
1246 | PUR 0110 | - | - | - | - | 1件: 97 97 💬
|
1247 | PUR 0110 rectal enema | - | - | - | - | 1件: 97 97 💬
|
1248 | PUR 0110 rectal enema 1000 MG | - | - | - | - | 1件: 97 97 💬
|
1249 | PUR 0110 rectal enema 250 MG | - | - | - | - | 1件: 97 97 💬
|
1250 | PUR 0110 rectal enema 500 MG | - | - | - | - | 1件: 97 97 💬
|
1251 | Pure give pectin 20G/D FOR five days | - | - | - | - | 1件: 97 97 💬
|
1252 | Puri nethol | - | - | - | - | 2件: 96 96, 97 💬
|
1253 | PURI-nethol | - | - | - | - | 3件: 86 86, 96, 97 💬
|
1254 | Qbeco | - | - | - | - | 2件: 96 96, 97 💬
|
1255 | Qbeco SSI | - | - | - | - | 1件: 97 97 💬
|
1256 | Quadrivalent HPV vaccine | - | - | - | - | 2件: 97 97, 107 💬
|
1257 | Questionnaire administration | - | - | - | - | 7件: 16 16, 28, 34, 51, 60, 97, 298 💬
|
1258 | R-3750 | - | - | - | - | 1件: 97 97 💬
|
1259 | Ramosetron | 1件: Ramosetron Ramosetron | 2件: Ramosetron hydrochloride
Ramosetron hydrochloride
,
Ramosetron
💬
| 5件: HTR3 HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 97 97 💬
|
1260 | Randomized B-fructan diet | - | - | - | - | 1件: 97 97 💬
|
1261 | Ranolazine | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 7件: 2 2, 58, 86, 96, 97, 113, 114 💬
|
1262 | Ravagalimab | 1件: Ravagalimab Ravagalimab | 1件: Ravagalimab
Ravagalimab
💬
| 1件: TNFRSF5 TNFRSF5 💬
| 17件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | 3件: 46 46, 53, 97 💬
|
1263 | RCTB-401 | - | - | - | - | 2件: 96 96, 97 💬
|
1264 | RDP58 | 1件: RDP58 RDP58 | - | - | - | 1件: 97 97 💬
|
1265 | Rebamipide | 1件: Rebamipide Rebamipide | 1件: Rebamipide
Rebamipide
💬
| - | - | 4件: 46 46, 53, 97, 271 💬
|
1266 | Rectal dialysis | - | - | - | - | 1件: 97 97 💬
|
1267 | Rectal tacrolimus | - | - | - | - | 1件: 97 97 💬
|
1268 | Rectosigmoidoscopy | - | - | - | - | 1件: 97 97 💬
|
1269 | Regular treatment | - | - | - | - | 1件: 97 97 💬
|
1270 | Regulatory T cells | - | - | - | - | 2件: 95 95, 97 💬
|
1271 | Remestemcel-L | 1件: Remestemcel-L Remestemcel-L | 1件: Remestemcel-L
Remestemcel-L
💬
| - | - | 2件: 96 96, 97 💬
|
1272 | Remicade | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 46 46, 49, 56, 84, 85, 96, 97, 271 💬
|
1273 | Remicade 100 MG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 56 56, 96, 97 💬
|
1274 | Remicade 100 MG infuusiokuiva-aine, konsentraattiliuosta varten | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
1275 | Remicade 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
1276 | Remsima | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 💬
|
1277 | Remsima 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
1278 | Remsima and inflectra | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
1279 | Resveratrol supplementation | 1件: Resveratrol Resveratrol | - | - | - | 1件: 97 97 💬
|
1280 | Retarded release phosphatidylcholine | - | - | - | - | 1件: 97 97 💬
|
1281 | RHIL-11 | - | - | - | - | 2件: 96 96, 97 💬
|
1282 | Rhumab BETA7 | - | - | - | - | 1件: 97 97 💬
|
1283 | Rhumab BETA7, anti beta 7, PRO145223 | - | - | - | - | 1件: 97 97 💬
|
1284 | Rhumab BETA7, anti BETA7, PRO145223 | - | - | - | - | 1件: 97 97 💬
|
1285 | Riboflavin | 1件: Riboflavin Riboflavin | 1件: Riboflavin
Riboflavin
💬
| - | - | 7件: 13 13, 38, 46, 97, 162, 168, 265 💬
|
1286 | Rifampicin | 1件: Rifampin Rifampin | 2件: Rifampin
Rifampin
,
Rifampicin sodium
💬
| - | - | 8件: 6 6, 13, 17, 46, 93, 97, 299, 338 💬
|
1287 | Rifaximin | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 8件: 6 6, 65, 93, 96, 97, 99, 296, 299 💬
|
1288 | Risankizumab | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 4件: 37 37, 96, 97, 271 💬
|
1289 | Risankizumab IV | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
1290 | Risankizumab SC | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
1291 | Risankizumab-800CW 15 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
1292 | Risankizumab-800CW 25 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
1293 | Risankizumab-800CW 4.5 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
1294 | Risankizumab-800CW optimal dose | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
1295 | Ritlecitinib | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1296 | Ritlecitinib 10 MG | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1297 | Ritlecitinib 5 MG | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1298 | Ritlecitinib 50 MG | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 2件: 96 96, 97 💬
|
1299 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
1300 | Rivenprost | 1件: Rivenprost Rivenprost | - | - | - | 1件: 97 97 💬
|
1301 | RNA analysis | - | - | - | - | 3件: 28 28, 60, 97 💬
|
1302 | RO 549-0261/F04 | - | - | - | - | 1件: 97 97 💬
|
1303 | RO5490261 / F02 | - | - | - | - | 1件: 97 97 💬
|
1304 | RO5490261/F02 | - | - | - | - | 2件: 96 96, 97 💬
|
1305 | RO7049665 | - | - | - | - | 2件: 95 95, 97 💬
|
1306 | RO7246311 | - | - | - | - | 1件: 97 97 💬
|
1307 | RO7790121 | - | - | - | - | 2件: 96 96, 97 💬
|
1308 | RO7837195 | - | - | - | - | 1件: 97 97 💬
|
1309 | Roflumilast | 1件: Roflumilast Roflumilast | 1件: Roflumilast
Roflumilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 4件: 84 84, 97, 206, 299 💬
|
1310 | Ropivacaine | 1件: Ropivacaine Ropivacaine | 2件: Ropivacaine hydrochloride
Ropivacaine hydrochloride
,
Ropivacaine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 5件: 22 22, 36, 46, 70, 97 💬
|
1311 | Rosiglitazone | 1件: Rosiglitazone Rosiglitazone | 2件: Rosiglitazone maleate
Rosiglitazone maleate
,
Rosiglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 3件: 77 77, 97, 222 💬
|
1312 | Rosnilimab | 1件: Rosnilimab Rosnilimab | 1件: Rosnilimab
Rosnilimab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 2件: 46 46, 97 💬
|
1313 | Rosuvastatin 10MG | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 97 97 💬
|
1314 | Rosuvastatin calcium | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 4件: 49 49, 79, 97, 299 💬
|
1315 | Rosuvastatine EG | - | - | - | - | 1件: 97 97 💬
|
1316 | RPC1063 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
1317 | RTNV148B IGG | - | - | - | - | 3件: 46 46, 97, 271 💬
|
1318 | RVG 114681 | - | - | - | - | 2件: 96 96, 97 💬
|
1319 | RVG 116648 | - | - | - | - | 2件: 96 96, 97 💬
|
1320 | RVG00859 | - | - | - | - | 2件: 96 96, 97 💬
|
1321 | RYAH-medtech inhaler | - | - | - | - | 5件: 2 2, 6, 13, 96, 97 💬
|
1322 | Saffron | - | - | - | - | 1件: 97 97 💬
|
1323 | Saffron 100 | - | - | - | - | 1件: 97 97 💬
|
1324 | Saffron 50 | - | - | - | - | 1件: 97 97 💬
|
1325 | Saffron supplement FOR IBD | - | - | - | - | 1件: 97 97 💬
|
1326 | Saline | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 19件: 2 2, 6, 13, 17, 18, 46, 53, 67, 77, 86, 96, 97, 98, 168, 256, 271, 274, 299, 301 💬
|
1327 | Saline +5% albumin | - | - | - | - | 1件: 97 97 💬
|
1328 | Salmon | 1件: Salmon, unspecified Salmon, unspecified | - | - | - | 3件: 96 96, 97, 225 💬
|
1329 | Salofalk | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
1330 | Salofalk 1000MG granu-stix | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1331 | Salofalk 3G gastro-resistant prolonged-release granules | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1332 | Salofalk 4G/60ML klysma | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1333 | Salofalk granu-stix 500 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1334 | Salofalk® 500 MG gastro-resistant tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1335 | Salofalk® 500 MG tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1336 | Salofalk® 500MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1337 | Sampling | - | - | - | - | 1件: 97 97 💬
|
1338 | Sandimmum | - | - | - | - | 1件: 97 97 💬
|
1339 | Sandimmun | - | - | - | - | 2件: 97 97, 226 💬
|
1340 | Sandimmun 50 MG/ML, infuusiokonsentraatti | - | - | - | - | 1件: 97 97 💬
|
1341 | Sandimmun neoral | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 54 54, 60, 97, 226 💬
|
1342 | Sandinum | - | - | - | - | 1件: 97 97 💬
|
1343 | SAR339658 | - | - | - | - | 2件: 13 13, 97 💬
|
1344 | SAR441566 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
1345 | SAR442970 | - | - | - | - | 2件: 97 97, 222 💬
|
1346 | SAR443122 | 1件: SAR443122 SAR443122 | 1件: Eclitasertib
Eclitasertib
💬
| 1件: RIPK1 RIPK1 💬
| 16件: Alcoholic liver disease Alcoholic liver disease, Apoptosis, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis C, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Pathogenic Escherichia coli infection, RIG-I-like receptor signaling pathway, Salmonella infection, Shigellosis, TNF signaling pathway, Toll-like receptor signaling pathway 💬 | 1件: 97 97 💬
|
1347 | SB-656933 | - | - | - | - | 1件: 97 97 💬
|
1348 | SB-656933 tablets | - | - | - | - | 2件: 97 97, 299 💬
|
1349 | SB012 | - | - | - | - | 1件: 97 97 💬
|
1350 | SB5 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
1351 | SC tulisokibart | - | - | - | - | 2件: 96 96, 97 💬
|
1352 | SC12267 | 1件: SC12267 SC12267 | - | - | - | 3件: 46 46, 96, 97 💬
|
1353 | SCH 900050 | - | - | - | - | 1件: 97 97 💬
|
1354 | SCI-B-VAC | - | - | - | - | 1件: 97 97 💬
|
1355 | Selg*OS polv 4bust 70G 1LT | - | - | - | - | 1件: 97 97 💬
|
1356 | SEMI-vegetarian diet | - | - | - | - | 1件: 97 97 💬
|
1357 | Sequential FMT | - | - | - | - | 1件: 97 97 💬
|
1358 | SER-287 | 1件: SER-287 SER-287 | - | - | - | 1件: 97 97 💬
|
1359 | Serum albumin level | 1件: Albumin human Albumin human | 2件: Albumin human
Albumin human
,
Human serum albumin
💬
| - | - | 1件: 97 97 💬
|
1360 | Serum calcium level | - | - | - | - | 1件: 97 97 💬
|
1361 | Serum creatinine | - | - | - | - | 1件: 97 97 💬
|
1362 | Serum leucine-rich alpha-2 glycoprotein (LRG) levels | - | - | - | - | 2件: 96 96, 97 💬
|
1363 | Serum phosphurus level | - | - | - | - | 1件: 97 97 💬
|
1364 | Serum potassium level | - | - | - | - | 1件: 97 97 💬
|
1365 | Serum total 25 hydroxycholecalciferol 25(OH) vitamin D | - | - | - | - | 1件: 97 97 💬
|
1366 | Seum alanine aminotransferase | - | - | - | - | 1件: 97 97 💬
|
1367 | SF257 C59 | - | - | - | - | 1件: 97 97 💬
|
1368 | Sham hyperbaric AIR | - | - | - | - | 1件: 97 97 💬
|
1369 | Shingrix | - | - | - | - | 4件: 46 46, 49, 96, 97 💬
|
1370 | SHP647 | - | - | - | - | 2件: 96 96, 97 💬
|
1371 | SHR0302 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
1372 | SHR0302 tablets | - | - | - | - | 2件: 46 46, 97 💬
|
1373 | Sigmoidoscopy | - | - | - | - | 1件: 97 97 💬
|
1374 | Silymarin | - | - | - | - | 2件: 46 46, 97 💬
|
1375 | Simponi | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 97, 271 💬
|
1376 | Simponi 100 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
1377 | Simponi 50 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
1378 | Simulect | 1件: Basiliximab Basiliximab | 1件: Basiliximab
Basiliximab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 66 66, 97 💬
|
1379 | Single DOSE-group A | - | - | - | - | 1件: 97 97 💬
|
1380 | Single fecal microbiota transplantation | - | - | - | - | 1件: 97 97 💬
|
1381 | Single FMT | - | - | - | - | 1件: 97 97 💬
|
1382 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 39件: 6 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
1383 | Smartject device delivery OF golimumab | - | - | - | - | 1件: 97 97 💬
|
1384 | Smoking cigarettes | - | - | - | - | 2件: 96 96, 97 💬
|
1385 | Smoking OF cannabis | - | - | - | - | 2件: 96 96, 97 💬
|
1386 | Sodio solfato anidro | - | - | - | - | 1件: 97 97 💬
|
1387 | Sodium | - | - | - | - | 1件: 97 97 💬
|
1388 | Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate | - | - | - | - | 1件: 97 97 💬
|
1389 | Sodium ascorbate | 2件: Ascorbic acid Ascorbic acid, Sodium ascorbate | 2件: Ascorbic acid
Ascorbic acid
,
Sodium ascorbate
💬
| - | - | 1件: 97 97 💬
|
1390 | Sodium bicarbonate | 1件: Sodium bicarbonate Sodium bicarbonate | 1件: Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | 3件: 97 97, 226, 299 💬
|
1391 | Sodium bicarbonate BP | 1件: Sodium bicarbonate Sodium bicarbonate | 1件: Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | 2件: 97 97, 299 💬
|
1392 | Sodium chloride | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 20件: 2 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
|
1393 | Sodium hyaluronate | 1件: Hyaluronic acid Hyaluronic acid | 2件: Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | 3件: 53 53, 97, 226 💬
|
1394 | Sodium picosulfate/magnesium citrate laxative | - | - | - | - | 1件: 97 97 💬
|
1395 | Sodium sulfate anhydrous | 1件: Sodium sulfate Sodium sulfate | 2件: Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | 1件: 97 97 💬
|
1396 | Sodium sulphate anhydrous | 1件: Sodium sulfate Sodium sulfate | 2件: Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | 1件: 97 97 💬
|
1397 | Solfato DI sodio anidro | - | - | - | - | 1件: 97 97 💬
|
1398 | SOLU-medrol | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 4件: 13 13, 51, 97, 211 💬
|
1399 | Somatropin | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 18件: 2 2, 3, 19, 74, 75, 78, 96, 97, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬
|
1400 | Sonovue | 1件: Sulfur hexafluoride Sulfur hexafluoride | 1件: Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | 2件: 96 96, 97 💬
|
1401 | SOR102 | - | - | - | - | 1件: 97 97 💬
|
1402 | Sorbitol sachet | 1件: Sorbitol Sorbitol | 1件: Sorbitol solution
Sorbitol solution
💬
| - | - | 1件: 97 97 💬
|
1403 | Sotrastaurin (INN) acetate | 1件: Sotrastaurin Sotrastaurin | 2件: Sotrastaurin
Sotrastaurin
,
Sotrastaurin acetate
💬
| 4件: PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬
| 29件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 97 97 💬
|
1404 | Soybean phosphatidylcholine | 1件: Soybean Soybean | - | - | - | 1件: 97 97 💬
|
1405 | SPD476 | - | - | - | - | 1件: 97 97 💬
|
1406 | SPD476 IS A polymeric matrix formulation that displays both delayed- and extended-release OF mesalazine | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1407 | Spesolimab | 1件: Spesolimab Spesolimab | 1件: Spesolimab
Spesolimab
💬
| 1件: IL1RL2 IL1RL2 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 5件: 37 37, 96, 97, 160, 269 💬
|
1408 | Spesolimab IV infusion | 1件: Spesolimab Spesolimab | 1件: Spesolimab
Spesolimab
💬
| 1件: IL1RL2 IL1RL2 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 97 97 💬
|
1409 | Spesolimab SC solution FOR injection | 1件: Spesolimab Spesolimab | 1件: Spesolimab
Spesolimab
💬
| 1件: IL1RL2 IL1RL2 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 97 97 💬
|
1410 | SPH3127 | - | - | - | - | 1件: 97 97 💬
|
1411 | SPH3127 tablets with dose A | - | - | - | - | 1件: 97 97 💬
|
1412 | SPH3127 tablets with dose B | - | - | - | - | 1件: 97 97 💬
|
1413 | SPH7854 | - | - | - | - | 1件: 97 97 💬
|
1414 | SR140333B | - | - | - | - | 1件: 97 97 💬
|
1415 | SRT2104 | - | - | - | - | 1件: 97 97 💬
|
1416 | ST 261 | - | - | - | - | 1件: 97 97 💬
|
1417 | ST-0529 | - | - | - | - | 1件: 97 97 💬
|
1418 | ST10 | - | - | - | - | 2件: 96 96, 97 💬
|
1419 | ST10-021 | - | - | - | - | 2件: 96 96, 97 💬
|
1420 | ST261 | - | - | - | - | 1件: 97 97 💬
|
1421 | Standard 2 hours-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
1422 | Standard hepatitis B vaccine | - | - | - | - | 1件: 97 97 💬
|
1423 | Standard therapy | - | - | - | - | 5件: 49 49, 51, 58, 97, 195 💬
|
1424 | Standardized anthocyanin-rich extract | - | - | - | - | 1件: 97 97 💬
|
1425 | Standardized FMT | - | - | - | - | 1件: 97 97 💬
|
1426 | Standardized fodmap | - | - | - | - | 1件: 97 97 💬
|
1427 | Stelara | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 6件: 49 49, 56, 96, 97, 269, 271 💬
|
1428 | Stelara - 45 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 0.5 ML (90 MG/ML) 1 flaconcino | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1429 | Stelara - 90 MG - soluzione iniettabile IN siringhe preriempite - USO sottocutaneo - siringa preriempita(vetro) 1 ML(90MG/ML) 1 siringa preriempita DA 1 ML | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1430 | Stelara - 90 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 1.0 ML (90 MG/ML) 1 flaconcino | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1431 | Stelara® | - | - | - | - | 2件: 96 96, 97 💬
|
1432 | Sterile saline FOR injection | - | - | - | - | 1件: 97 97 💬
|
1433 | Steroids | - | - | - | - | 6件: 46 46, 50, 51, 63, 96, 97 💬
|
1434 | STNM01 1.84 MG | - | - | - | - | 1件: 97 97 💬
|
1435 | Stool samples | - | - | - | - | 1件: 97 97 💬
|
1436 | STW5-II | - | - | - | - | 1件: 97 97 💬
|
1437 | SUB20016 | - | - | - | - | 2件: 96 96, 97 💬
|
1438 | Sucrosomial iron | - | - | - | - | 1件: 97 97 💬
|
1439 | Sugar extract | - | - | - | - | 2件: 96 96, 97 💬
|
1440 | Sulfur hexafluoride | 1件: Sulfur hexafluoride Sulfur hexafluoride | 1件: Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | 3件: 96 96, 97, 215 💬
|
1441 | Sulphsalazine, pentasa, asacol, colazide, depentum | - | - | - | - | 1件: 97 97 💬
|
1442 | Sulphur hexafluoride | 1件: Sulfur hexafluoride Sulfur hexafluoride | 1件: Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | 2件: 96 96, 97 💬
|
1443 | Suspension containing 7500 embryonated viable trichuris suis OVA/15ML | - | - | - | - | 1件: 97 97 💬
|
1444 | Suspension DE microbiote FéCAL | - | - | - | - | 1件: 97 97 💬
|
1445 | Suspension OF adipose derived autologous adult stem cells | - | - | - | - | 2件: 96 96, 97 💬
|
1446 | Synergy-1 | - | - | - | - | 1件: 97 97 💬
|
1447 | Synergy1 | - | - | - | - | 1件: 97 97 💬
|
1448 | Süßholzwurzel 1ML/10ML | - | - | - | - | 1件: 97 97 💬
|
1449 | TA-650 | - | - | - | - | 4件: 37 37, 56, 96, 97 💬
|
1450 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 31件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
|
1451 | Tacrolimus lipid suspension FOR enema | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 97 97 💬
|
1452 | TAK-279 | - | - | - | - | 3件: 37 37, 96, 97 💬
|
1453 | Tauroursoursodeoxycholic acid, brand name tudcabil | - | - | - | - | 1件: 97 97 💬
|
1454 | TD-1473 | - | - | - | - | 2件: 96 96, 97 💬
|
1455 | TD-1473 dose A | - | - | - | - | 1件: 97 97 💬
|
1456 | TD-1473 dose B | - | - | - | - | 1件: 97 97 💬
|
1457 | TD-1473 dose C | - | - | - | - | 1件: 97 97 💬
|
1458 | TD-3504 | - | - | - | - | 1件: 97 97 💬
|
1459 | Telotristat etiprate | 1件: Telotristat Telotristat | 1件: Telotristat
Telotristat
💬
| 2件: TPH1_2 TPH1_2, TPH1_2 💬
| 3件: Folate biosynthesis Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬 | 1件: 97 97 💬
|
1460 | Terbinafine | 1件: Terbinafine Terbinafine | 2件: Terbinafine hydrochloride
Terbinafine hydrochloride
,
Terbinafine
💬
| - | - | 2件: 96 96, 97 💬
|
1461 | Terbinafine tablets | 1件: Terbinafine Terbinafine | 2件: Terbinafine hydrochloride
Terbinafine hydrochloride
,
Terbinafine
💬
| - | - | 2件: 97 97, 271 💬
|
1462 | Tetomilast | 1件: Tetomilast Tetomilast | - | - | - | 2件: 96 96, 97 💬
|
1463 | Tetracycline | 1件: Tetracycline Tetracycline | 2件: Tetracycline
Tetracycline
,
Tetracycline hydrochloride
💬
| - | - | 5件: 13 13, 46, 53, 66, 97 💬
|
1464 | TEV-48574 | - | - | - | - | 2件: 96 96, 97 💬
|
1465 | TEV-48574 dose regimen A | - | - | - | - | 2件: 96 96, 97 💬
|
1466 | TEV-48574 dose regiment B | - | - | - | - | 2件: 96 96, 97 💬
|
1467 | Thalidomide | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300 💬
|
1468 | Thalidomide pharmion | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 85 85, 96, 97 💬
|
1469 | Therapy education | - | - | - | - | 1件: 97 97 💬
|
1470 | Thiamin | 1件: Thiamine Thiamine | 3件: Thiamine hydrochloride
Thiamine hydrochloride
,
Thiamine mononitrate
,
Thiamine
💬
| - | - | 1件: 97 97 💬
|
1471 | Thiopurine | - | - | - | - | 2件: 96 96, 97 💬
|
1472 | Thiosix | - | - | - | - | 2件: 96 96, 97 💬
|
1473 | Threonine | 1件: Threonine Threonine | 1件: Threonine
Threonine
💬
| - | - | 3件: 86 86, 96, 97 💬
|
1474 | THRX-139060 | - | - | - | - | 2件: 96 96, 97 💬
|
1475 | Tiamin DAK | - | - | - | - | 2件: 93 93, 97 💬
|
1476 | Tiamin SAD | - | - | - | - | 2件: 93 93, 97 💬
|
1477 | Tilpisertib | 1件: Tilpisertib Tilpisertib | - | - | - | 1件: 97 97 💬
|
1478 | Tilpisertib fosmecarbil | 2件: Tilpisertib Tilpisertib, Tilpisertib fosmecarbil | - | - | - | 1件: 97 97 💬
|
1479 | Time and attention + active fructooligosaccharide supplementation | - | - | - | - | 2件: 96 96, 97 💬
|
1480 | Tirzepatide | 1件: Tirzepatide Tirzepatide | 1件: Tirzepatide
Tirzepatide
💬
| 2件: GIPR GIPR, GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 67 67, 96, 97, 193, 233 💬
|
1481 | Tissucol DUO (5.0ML) fibrin tissue adhesive | - | - | - | - | 1件: 97 97 💬
|
1482 | TJ301 300MG | - | - | - | - | 1件: 97 97 💬
|
1483 | TJ301 600MG | - | - | - | - | 1件: 97 97 💬
|
1484 | TLL018 | - | - | - | - | 1件: 97 97 💬
|
1485 | TNF inhibitor | - | - | - | - | 3件: 46 46, 97, 107 💬
|
1486 | TNF inhibitors | - | - | - | - | 2件: 46 46, 97 💬
|
1487 | TNF-A antagonists, NON-tnfs, dmard NON-biologics | - | - | - | - | 3件: 46 46, 97, 271 💬
|
1488 | TO BE confirmed | - | - | - | - | 3件: 46 46, 65, 97 💬
|
1489 | TO BE requested | - | - | - | - | 2件: 96 96, 97 💬
|
1490 | Tofacinitib | - | - | - | - | 1件: 97 97 💬
|
1491 | Tofacitinib | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 19件: 35 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 96, 97, 107, 110, 162, 271, 300 💬
|
1492 | Tofacitinib citrate | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 5件: 46 46, 49, 97, 107, 271 💬
|
1493 | Tofacitinib plus mesalamine | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1494 | TOP down treatment IF patient AT high risk | - | - | - | - | 2件: 96 96, 97 💬
|
1495 | TOP1288 | - | - | - | - | 1件: 97 97 💬
|
1496 | TOP1288 rectal solution | - | - | - | - | 1件: 97 97 💬
|
1497 | TP05 | - | - | - | - | 1件: 97 97 💬
|
1498 | TP05 coating A | - | - | - | - | 1件: 97 97 💬
|
1499 | TP05 coating B | - | - | - | - | 1件: 97 97 💬
|
1500 | TP05 coating D | - | - | - | - | 1件: 97 97 💬
|
1501 | TP05 coating E | - | - | - | - | 1件: 97 97 💬
|
1502 | TP05 coating H | - | - | - | - | 1件: 97 97 💬
|
1503 | Tpmt genotyping | - | - | - | - | 2件: 96 96, 97 💬
|
1504 | TQH3906 capsules | - | - | - | - | 2件: 96 96, 97 💬
|
1505 | Traditional treatments | - | - | - | - | 1件: 97 97 💬
|
1506 | Tralokinumab | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 2件: 85 85, 97 💬
|
1507 | Transcriptomic analysis | - | - | - | - | 2件: 50 50, 97 💬
|
1508 | Treatment algorithm A | - | - | - | - | 1件: 97 97 💬
|
1509 | Treatment algorithm B | - | - | - | - | 1件: 97 97 💬
|
1510 | Treatment algorithm C | - | - | - | - | 1件: 97 97 💬
|
1511 | Treatment group: rectal instillation OF qhqyp | - | - | - | - | 1件: 97 97 💬
|
1512 | Treatment VS control bread | - | - | - | - | 1件: 97 97 💬
|
1513 | Trexan INJ 25 MG/ML | - | - | - | - | 1件: 97 97 💬
|
1514 | Trichuris suis eggs | - | - | - | - | 3件: 13 13, 96, 97 💬
|
1515 | Trichuris suis OVA | - | - | - | - | 4件: 13 13, 46, 96, 97 💬
|
1516 | Trilac | - | - | - | - | 2件: 96 96, 97 💬
|
1517 | Tris | 1件: Tromethamine Tromethamine | 1件: Tromethamine
Tromethamine
💬
| - | - | 2件: 96 96, 97 💬
|
1518 | TSO | - | - | - | - | 3件: 13 13, 46, 97 💬
|
1519 | Tulisokibart | 1件: Tulisokibart Tulisokibart | 1件: Tulisokibart
Tulisokibart
💬
| 1件: TNFSF15 TNFSF15 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 3件: 51 51, 96, 97 💬
|
1520 | Tumor necrosis factor (TNF)-alpha inhibitors | - | - | - | - | 1件: 97 97 💬
|
1521 | Twice daily 90 MG hydrocortisone acetate suppository administered with sephure applicator | 3件: Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | 2件: Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
1522 | TYK2 inhibitor | - | - | - | - | 1件: 97 97 💬
|
1523 | UCB4940 | - | - | - | - | 3件: 46 46, 97, 271 💬
|
1524 | Ucmsc group | - | - | - | - | 1件: 97 97 💬
|
1525 | Udca | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 5件: 67 67, 93, 94, 97, 296 💬
|
1526 | Ulcerative colitis diet | - | - | - | - | 1件: 97 97 💬
|
1527 | Ulcerative colitis exclusion diet | - | - | - | - | 1件: 97 97 💬
|
1528 | Umbilical cord blood mononuclear cells | - | - | - | - | 1件: 97 97 💬
|
1529 | Umbilical cord mesenchymal stem cells | - | - | - | - | 5件: 13 13, 46, 57, 97, 113 💬
|
1530 | Undetermined | - | - | - | - | 2件: 96 96, 97 💬
|
1531 | Unknown | - | - | - | - | 3件: 34 34, 67, 97 💬
|
1532 | Upadacitinib | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 10件: 40 40, 41, 46, 49, 53, 55, 96, 97, 107, 271 💬
|
1533 | Upadacitinib - direct compression-yellow | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1534 | Upadacitinib - WET granulation-yellow | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1535 | Upadacitinib -direct compression-yellow | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1536 | Upadacitinib extended release oral tablet | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1537 | Upadacitinib oral product | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
1538 | UR-12746-S | - | - | - | - | 1件: 97 97 💬
|
1539 | Urbason | - | - | - | - | 1件: 97 97 💬
|
1540 | Ursodeoxycholic acid | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 8件: 6 6, 67, 84, 93, 94, 95, 96, 97 💬
|
1541 | Ursodiol | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 6件: 8 8, 20, 93, 97, 234, 299 💬
|
1542 | Ursofalk | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 4件: 93 93, 94, 96, 97 💬
|
1543 | US TAP bupivacaine/epinephrine | - | - | - | - | 2件: 96 96, 97 💬
|
1544 | Ustekinumab | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 16件: 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
|
1545 | Ustekinumab - standard dosage | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1546 | Ustekinumab 130 MG IV | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1547 | Ustekinumab 90 MG | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 5件: 49 49, 50, 93, 96, 97 💬
|
1548 | Ustekinumab 90 MG SC Q12W | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1549 | Ustekinumab 90 MG SC Q8W | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1550 | Ustekinumab dose based ON BSA and body weight | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 97 97 💬
|
1551 | Ustekinumab IV | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 49 49, 97 💬
|
1552 | Ustekinumab IV infusion | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1553 | Ustekinumab SC | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 49 49, 97 💬
|
1554 | Ustekinumab SC injection | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
1555 | Usual current care | - | - | - | - | 2件: 96 96, 97 💬
|
1556 | UTTR1147A | - | - | - | - | 2件: 96 96, 97 💬
|
1557 | UTTR1147A, IL22-FC, IL-22FC | 1件: Efmarodocokin alfa Efmarodocokin alfa | 1件: Efmarodocokin alfa
Efmarodocokin alfa
💬
| 1件: IL22 IL22 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬
|
1558 | V565 | - | - | - | - | 2件: 96 96, 97 💬
|
1559 | Vaccination against cholera | - | - | - | - | 1件: 97 97 💬
|
1560 | Vaccine | - | - | - | - | 6件: 46 46, 49, 51, 96, 97, 271 💬
|
1561 | Vaccine ANTI-H1n1 | - | - | - | - | 1件: 97 97 💬
|
1562 | Vaccine vivotif + vaccine dukoral + oats | - | - | - | - | 1件: 97 97 💬
|
1563 | Valganciclovir | 1件: Valganciclovir Valganciclovir | 2件: Valganciclovir
Valganciclovir
,
Valganciclovir hydrochloride
💬
| - | - | 6件: 28 28, 60, 85, 97, 299, 331 💬
|
1564 | Vaminolac | - | - | - | - | 1件: 97 97 💬
|
1565 | Vamorolone 4% suspension FOR oral dosing | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
1566 | Vancomicina cloridrato | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 2件: 94 94, 97 💬
|
1567 | Vancomycin | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 💬
|
1568 | Vancomycin oral capsule | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 1件: 97 97 💬
|
1569 | Vancomycin PRE-treat | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 1件: 97 97 💬
|
1570 | Vancomycin PRE-treatment | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 1件: 97 97 💬
|
1571 | Vancomycin, mupirocin ointment | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 1件: 97 97 💬
|
1572 | Vatelizumab | 1件: Vatelizumab Vatelizumab | - | - | - | 2件: 13 13, 97 💬
|
1573 | VB-201 | 1件: VB-201 VB-201 | - | - | - | 1件: 97 97 💬
|
1574 | VB-201 160MG | 1件: VB-201 VB-201 | - | - | - | 1件: 97 97 💬
|
1575 | VE202 | - | - | - | - | 1件: 97 97 💬
|
1576 | Vedolizumab | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 💬
|
1577 | Vedolizumab 108 MG SC | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 97 97 💬
|
1578 | Vedolizumab 300 MG | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
1579 | Vedolizumab 300 MG IV | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 97 97 💬
|
1580 | Vedolizumab injection | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 97 97 💬
|
1581 | Vedolizumab intravenous injection | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
1582 | Vedolizumab IV | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 💬
|
1583 | Vedolizumab SC | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
1584 | Vedolizumab SC 108 MG | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
1585 | Vedolizumab subcutaneous injection | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
1586 | Vedolizumab, entyvio | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
1587 | Vedolizumab, ustekinumab, or tofacitinib | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 97 97 💬
|
1588 | Vedulizumab | - | - | - | - | 1件: 97 97 💬
|
1589 | Vegan drink | - | - | - | - | 1件: 97 97 💬
|
1590 | Vegetarian meat alternative | - | - | - | - | 1件: 97 97 💬
|
1591 | Vegetarian yogurt | - | - | - | - | 1件: 97 97 💬
|
1592 | Venlafaxine | 1件: Venlafaxine Venlafaxine | 3件: Venlafaxine hydrochloride
Venlafaxine hydrochloride
,
Venlafaxine
,
Venlafaxine besylate monohydrate
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 97 💬
|
1593 | Venofer | 1件: Iron sucrose Iron sucrose | 1件: Iron sucrose
Iron sucrose
💬
| - | - | 1件: 97 97 💬
|
1594 | Venofer solution FOR injection, 100 MG iron | 1件: Iron sucrose Iron sucrose | 1件: Iron sucrose
Iron sucrose
💬
| - | - | 1件: 97 97 💬
|
1595 | Venofer solution FOR injection, 20 MG iron/ML | 1件: Iron sucrose Iron sucrose | 1件: Iron sucrose
Iron sucrose
💬
| - | - | 1件: 97 97 💬
|
1596 | Venofer solution FOR injection, 20 MG/ML iron | 1件: Iron sucrose Iron sucrose | 1件: Iron sucrose
Iron sucrose
💬
| - | - | 1件: 97 97 💬
|
1597 | Vidofludimus calcium | 1件: Vidofludimus Vidofludimus | 2件: Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 4件: 13 13, 94, 96, 97 💬
|
1598 | Vidofludimus calcium dihydrate | 1件: Vidofludimus Vidofludimus | 2件: Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 97 97 💬
|
1599 | Vigantol OEL TM | - | - | - | - | 2件: 96 96, 97 💬
|
1600 | Visilizumab | 1件: Visilizumab Visilizumab | 1件: Visilizumab
Visilizumab
💬
| 3件: CD3D CD3D, CD3E, CD3G 💬
| 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬
|
1601 | Visilizumab (HUM291 | 1件: Visilizumab Visilizumab | 1件: Visilizumab
Visilizumab
💬
| 3件: CD3D CD3D, CD3E, CD3G 💬
| 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 97 97 💬
|
1602 | VIT-45 | - | - | - | - | 1件: 97 97 💬
|
1603 | Vitamin B2 | 1件: Riboflavin Riboflavin | 1件: Riboflavin
Riboflavin
💬
| - | - | 1件: 97 97 💬
|
1604 | Vitamin B5 tablets | 1件: Pantothenic acid Pantothenic acid | 3件: Calcium pantothenate
Calcium pantothenate
,
Pantothenic acid
,
Sodium pantothenate
💬
| - | - | 1件: 97 97 💬
|
1605 | Vitamin B6 tablets | 1件: Pyridoxine Pyridoxine | 2件: Pyridoxine hydrochloride
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | 1件: 97 97 💬
|
1606 | Vitamin D | 1件: Vitamin D Vitamin D | - | - | - | 20件: 6 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
|
1607 | Vitamin D drops | 1件: Vitamin D Vitamin D | - | - | - | 2件: 96 96, 97 💬
|
1608 | Vitamin D enriched milk | 1件: Vitamin D Vitamin D | - | - | - | 1件: 97 97 💬
|
1609 | Vitamin D-3 | 2件: Cholecalciferol Cholecalciferol, Vitamin D | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 97 97 💬
|
1610 | Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 11件: 6 6, 13, 20, 46, 49, 51, 53, 65, 96, 97, 299 💬
|
1611 | Vitamin E 800IU | 1件: Vitamin E Vitamin E | 1件: Vitamin E
Vitamin E
💬
| - | - | 2件: 96 96, 97 💬
|
1612 | Vitamin K | 1件: Phylloquinone Phylloquinone | 1件: Phytonadione
Phytonadione
💬
| - | - | 3件: 13 13, 46, 97 💬
|
1613 | Vitamin K 10 MG | 1件: Phylloquinone Phylloquinone | 1件: Phytonadione
Phytonadione
💬
| - | - | 2件: 96 96, 97 💬
|
1614 | Vixarelimab | 1件: Vixarelimab Vixarelimab | 1件: Vixarelimab
Vixarelimab
💬
| 1件: OSMR OSMR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, PI3K-Akt signaling pathway 💬 | 3件: 51 51, 85, 97 💬
|
1615 | Vonoprazan | 1件: Vonoprazan Vonoprazan | 1件: Vonoprazan
Vonoprazan
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 3件: 63 63, 97, 98 💬
|
1616 | VSL#3 | - | - | - | - | 4件: 96 96, 97, 107, 291 💬
|
1617 | VTX002 | - | - | - | - | 1件: 97 97 💬
|
1618 | VTX002 IS NOT biologic | - | - | - | - | 1件: 97 97 💬
|
1619 | Warfarin 10 MG | 1件: Warfarin Warfarin | 3件: Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 2件: 96 96, 97 💬
|
1620 | Water | 1件: Water Water | 1件: Water
Water
💬
| - | - | 25件: 2 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
|
1621 | Water immersion | 1件: Water Water | 1件: Water
Water
💬
| - | - | 1件: 97 97 💬
|
1622 | Water or milk | 1件: Water Water | 1件: Water
Water
💬
| - | - | 1件: 97 97 💬
|
1623 | Wharton jelly mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
1624 | Whey | 1件: Whey Whey | - | - | - | 1件: 97 97 💬
|
1625 | Whey protein MILK-derived exosomes | 1件: Whey Whey | - | - | - | 1件: 97 97 💬
|
1626 | Xeljanz | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 97, 107, 271 💬
|
1627 | Xeljanz 5 MG FILM-coated tablets | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬
|
1628 | Xeljanz 5MG FILM-coated tablets | - | - | - | - | 1件: 97 97 💬
|
1629 | XMAB942 | - | - | - | - | 1件: 97 97 💬
|
1630 | Xylitol | 1件: Xylitol Xylitol | 1件: Xylitol
Xylitol
💬
| - | - | 3件: 53 53, 97, 299 💬
|
1631 | Zasocitinib | 1件: Zasocitinib Zasocitinib | 1件: Zasocitinib
Zasocitinib
💬
| 1件: TYK2 TYK2 💬
| 17件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | 2件: 96 96, 97 💬
|
1632 | Zeposia® indicated FOR THE treatment OF: relapsing forms OF multiple sclerosis, and active ulcerative colitis IN adults | - | - | - | - | 2件: 13 13, 97 💬
|
1633 | Zessly | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
1634 | Zessly, remsima, remicade | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
1635 | ZL-82 100MG | - | - | - | - | 2件: 46 46, 97 💬
|
1636 | ZL-82 12.5MG | - | - | - | - | 2件: 46 46, 97 💬
|
1637 | ZL-82 200MG | - | - | - | - | 2件: 46 46, 97 💬
|
1638 | ZL-82 25MG | - | - | - | - | 2件: 46 46, 97 💬
|
1639 | ZL-82 300MG | - | - | - | - | 2件: 46 46, 97 💬
|
1640 | ZL-82 450MG | - | - | - | - | 2件: 46 46, 97 💬
|
1641 | ZL-82 50MG | - | - | - | - | 2件: 46 46, 97 💬
|
1642 | ZL-82 600MG | - | - | - | - | 2件: 46 46, 97 💬
|
1643 | Zoenasa-1:4 | - | - | - | - | 1件: 97 97 💬
|
1644 | ZOL446 | - | - | - | - | 2件: 97 97, 274 💬
|
1645 | Zoledronic acid | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 13件: 6 6, 13, 46, 75, 77, 93, 95, 96, 97, 270, 274, 299, 333 💬
|
1646 | Zuoqing powder WAS dissolved IN 100ML normal saline, retained enema, once A night | - | - | - | - | 1件: 97 97 💬
|